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INTRODUCTION 
Occurrence and Function of 2,3-Diphosphoglycerate (D:FG). 
In 1925, Greenwald isolated from porcine blood a substance 
Hhich he found to be a diphosphate ester of 1-glyceric acid. He 
also isolated it from the blood of humans and dogs, and proposed 
that the compound be known as diphospho-1-glyceric acid (Greenwald, 
1925). Rapoport and Guest in 191+1 reported the presence of diphos-
phoglycerate in large amounts in the blood cells of many species, 
but still the compound had not been found in any other tissue, nor 
was there any information about its metabolic significance. By 
1939, kn01dedge of the function of the compound was such that it 
was recognized to be an intermediate of glycolysis, as that path-
way was then understood. 'l'he fact that D:FG was a charged species 
and contained labile phosphorus indicated that it contributed to the 
ionic eq_uilibrium of the blood, and participated in the phosphorus 
metabolism of the body (Guest and Rapoport, 1939). 
In 1950, it was reported by Rapoport and Luebring that 
there Has an enzyrn.e they called "diphosphoglycerate mutase" which 
catalyzed the formation of 2,3-diphosphoglycerate (DFG), although 
they still thought that the enzyme and its product were restricted 
to the erythrocyte. The discovery of DPG mutase in other tissues 
1 
2 
(Towne, Hodwell and Grisolia, 1957) lt;d to a survey 11hich resulted 
in a talulation of DPG levels and DPG mutase activity from 26 ani-
mal and plant sources (Grisolia and J()yce, 1959). 
The presence of DPG in other tissues vras explained vii th the 
discoveJ7 of its f'unction as a cofactor in the glycolytic conver-
sion of J-phosphoglyceric acid to 2-phosphoglyceric acid which was 
catalyzed by the enzyme phosphoglyceric acid mutase (Sutherland, 
Pasternak and Cori, 194·9). Tnis justified the presence of DIG in 
any tissue capable of glycolysis. Only catalytic amounts of DFG 
were required for this purpose (Rose, 1970), leaving the large 
amounts of DPG in erythrocytes still unexplained. In man, DFG is 
present in the erythrocyte at a concentration of approximately 1J 
micromo1es per gram of hemoglobin, which is approximately eq_uimolar 
with hemoglobin (Benesch and Benesch, 1970; BreHer and Eaton, 1971). 
This high a concentration for a cofactor is unusual. The loss of 
ATP to the cell by the circumvention of an ATP-producing step 
(1,3-diphosphoglycerate plus ADP yielding 3-phosphoglycerate and 
ATP) Hhen DFG is formed v10uld also make this accumulation disad-
vantageous from an energy perspective. 
Sugita and Chanutin (1963) presented the first evidence Hhich 
contributed to an explanation of this accumulation Hhen they noted 
that the intensity of a previously reported (Berry and Chanutin, 
1957) band representing "component B" in the electrophoretic 
pattern of a red cell hemolysate corresponded to the presence of 
.. ~ 3 
f(, 'Ihey offered the explanation that DIG formed a complex Hith D ,, 
hernolysa te proteins which altere i the electrophoretic mobili tJ· of 
th8 protein. 'Ih:is was consistent with the observation that D·L::x::;, 
as well as "component B," decreased to the point of disappearc:,nce 
when the blood was stored in Acid-Citrate-Dextrose (ACD) for .')0 
days at 4 ° C. This is in contrast to the usual observation U at 
minor components increase with bLood storage (Huisman and Schroeder, 
1971). 
This work was culminated Hhen Chanutin and his co-workers 
reported the finding that me, as well as ATP and GTP, decreased 
the oxygen affinity of hemoglobin (Ohanutin and Curnish, 1967). 
This paper Has published almost simultaneously 1-d th a report from 
another laboratory which drew the same conclusion (Benesch and 
Benesch, 196?). In the absence of DIC, the affinity of hemoglobin 
for oxygen is high (loH P50 ). Hhen an equimolar amount of DFG is 
added, the curve is dramatically shifted to the right (increase in 
P50 ) to loHer affinity, but the shape of the curve is unchanged. 
The individual alpha and beta hemoglobin subunits react 
with DPG differently. Neither oxy nor deoxy alpha subunits as 
monomers (Huehns, Shooter, Dance, Beaven and Shooter, 1961) bind 
DPG, but both oxy and deoxy beta subunits as betaft (or hemoglobin H) 
(Benesch, Ranney, Benesch and Smith, 1961) bind DFG equally well. 
Mercurated beta chains, which are unable to form tetramers, bind 
only minimal amounts of DFG (Bucci, Fronticelli, Ohiancone, Wyman, 
Antonini and Rossi-Fanelli, 1965). A The finding that beta4 binds 
.. 
DFG to the same extent in the ox;~ and deoxy fonn is in accord 
wi t:1 the Hell established fact tta t, unlike hemoglobin A, beta:~ 
doE-S not undergo a measurable conformational change upon oxyge:aa-
tio1 (Benesch and Benesch, 1961-1-). It is even more significant 
A that the beta4 tetramer behaves like the deoxy form of hemoglobin 
A i.1 bincling DR;, since it has been reported (Perutz and Hazzarello, 
196.)·) that the structure of betat both in the presence ancl absence 
of 0xygen closely resembles that of deoxyhemoglobin A rather than 
oxyhemoglobin A. 
1-Jhile it has been reported that de oxyhemoglobin binds a 
maximThu of one mole DFG per mole deoxyhemoglobin (Benesch and Benesch, 
1969) and oxyhemoglobin binds no DFG, there have been conflicting 
reports Hhich say that there is a tendency tovmrd a limit of tHo 
moles DIG per mole hemoglobin, and at higher levels of DIG, the 
saturation curves of oxy and deoxy hemoglobin become virtually 
indistinguishable (Carby, Gerber and deVerdier, 1969). Such con-
flicting reports point up the sensitivity of binding to the con-
ditions, such as salt concentration, pH and temperatlrre. Under 
conditions most resembling those j_n the red cell, the ratio of 
DFG per mole deoxyhemoglobin is about 1:1, and there is substan-
tially less binding to oxyhemoglobin than to deoxyhemoglobin 
(Huisman and Schroeder, 1971). 
When considering the potential site of binding of DFG to 
hemoglobin, the Benesch group (Benesch, Benesch and Enoki, 1968) 
came to the conclusion that DFG bound along the twofold axis of 
5 
symmetry in the central cav.Lty whose entrance in deoxyherroglobin 
was large enough to admit D::C: but in oxyhemoglobin was teo con-
stricted. Since isolated alpha chains in neither the oxy nor 
deoxy form bound D:FC-, no si+,es on the alpha chain were ccnsidered 
as binding sites. Their proposed binding site is near the C-terminus 
of the beta chain, due to the three-dimensional relations~ips of the 
cent::-al cavity in deoxy and oxy hemoglobin. 
These speculations are inconsistent ~-rith the following 
observations: 1) The reports that oxyhemoglobin also binds D:FC-. 
2) It is inconsistent to rule out possible binding sites on alpha 
monomers, which can't form tetramers, vrhile proposing that the 
tetrameric conformation is required for binding and while noting 
that mercura ted beta monomers liketlise don't bind D:FC-. J) The 
fact that other organic phosphates, notably ATP and inositol hexa-
phosphate(IHP), also affect the oxygen affinity of hemoglobin. The 
three organic phosphates differ markedly in molecular weight, size 
and shape, and although DFG can enter the central cavity of deoxy-
hemoglobin, this is unlikely for A'I'P and IHP. It is also unlikely 
that three compounds vii th such similar activities would act via 
different mechanisms (Chanutin and Curnish, 1967; Luque, Diederich 
and Grisolia, 1969; Benesch, Benesch and Yu, 1968). 
i'lhatever the binding site, it is clear noH that the unique 
function of the large amount of DPG in the red cell is to modulate 
6 
the delivery of oxygE'n by changing the affinity of hemoglobin for 
oxygen and thereby hfluer.cing the position of the hemoglobin-
oxygen dissociation curve. 
.. 
DFG I1eta bolism ~ 
::::.;:;...:.:-
7 
DIG is formed from the glycolytic intermediate 1,3-diphospho-
glycerate u..Dder the action of the enzyme dir:hosphoglycerate mutase 
(Rapoport ancl Lue bring, 19.50). This reaction takes place with the 
involvement of 3-phosphoglycc;rate as an apparent cofactor, in that, 
it does not ap"?ear in the stoichiometry. In fact, the reaction is 
an intermolecular transfer of a phosphate moiety from carbon-1 of 
1,J-diphosphoglycerate to carbon-2 of 3-phosphoglycerate, Hhere 3-
phosphoglycerate acts as a substrate, but is regenerated as a pro-
duct (Rose, 1970). The fact that the K for each substrate is not m 
a function of the concentration of the other is evidence for the 
formation of a ternary complex between the enzyme and the two 
substrates (Alberty, 19.56). 
Diphosphoglycerate mutase has a high affinity for its sub--
strates and for certain inhibitors and activators. K values of 
m 
0.53 micromolar for 1,3-diphosphoglycerate and 1 micromolar for 3-
phosphoglycerate have been found. DFG is a competitive inhibitor 
of the enzyme with respect to 1,3-diphosphoglycerate, exhibiting 
a K. of 0.85 micromolar, and is a non-competitive inhibitor rela-
l 
tive to 3-phosphoglycerate as substrate with a K. of 1.25 micro-
. l 
molar. other inhibitors are inorganic phosphate (competitive Hith 
3-phosphoglycerate with a K. of 314 micromolar) at levels close to 
l 
those found in the red cell, silver nitrate, p-mercurobenzoate 
(Rose, 1968) and phosphoglycolic acid (at concentrations greater 
than 0.4 millimolar). 
8 
··' 
;:-Mercaptoethanol is an activator of DFG mutase, and par-
tiallY restores the activity lost to o-mercurobenzoate and silver 
nitrate. 2-Fnosphoglycerate acts as an activator; it has the effect 
of lowering the Km for 3-phosphoglyce:::ate as well as increasing thE 
vmax' 
2-fho;:;phoglycerate may also act as an alternative phosphate 
acceptor to form DPG. HoHever, 3-phosphoglycerate remains the 
principal acceptor at all levels of 2-phosphoglycerate. This re-
mains true as 2-phosphoglycerate is increased to inhibitory levels 
(10% inbibition at 100 micromolar, 50% inhibition at 1,330 micromolar). 
Phosphoglycolic acid (concentrations less than 0.4 millimolar) is 
an activator and appears to overcome the inhibition of inorganic 
phosphate. In the absence of phosphate, there seems to be competi-
tion betHeen phofophoglycolate and 2-phosphoglycerate as activators. 
It seems that phosphoglycolate, 2-phosphoglycerate and inorganic 
phosphate all compete for a single site on the enzyme and bring about 
changes Hhich affect the K for 3-phosphoglycera·te (Hose, 1.968). 
m 
DFG is catabolized by hydrolysis to 3-phosphoglycerate, 
catalyzed by the enzyme diphosphoglycerate phosphatase. This was 
at one time thought to be a second activity of tbe enzyme monophos-
phoglycerate mutase, but has since been shown to be a distinct enzy-
matic entity (Rose, 1970; Harkness and Hoth, 1969). This enzyme is 
activated by certain anions. When chloride salts are added, there 
is a small increase in velocity whicb is greatly enhanced by the 
addition of inorganic phosphate. Ihosphate in the absence of chloride 
has little effect. The physiological level of chloride in the red 
... 
9 
11 of about 0.1 N is optimal for the activation of this phospha-Ct:L 
tase at phosphate concentrations near physiological. Therefore, 
changeE.; in the normal phosphate level, Hhich is about 0. 6 milli-
molar, would be expected to affect the rate of the enzymic' rE;action. 
H1osphoglycolate activates DPG phosphatase in place of inor-
ganic phosphate aml chloride ions. Other activators are sodium 
b:.sulfite (only active in presence of chloride as a substitute for 
phosphate), dithionite, sulfite and sodiUJn cyanide (Harkness and 
Roth, 1969; Rose, 1970). 
Under normal physiological conditions, about 20% of the 
total g1ycolytic flux passes through the DFG pool (Gerlach and 
Duhm, 1971). Tnis has significs.nce not only for the level of DPG 
at any given time, but also from the point of vievr of energy con-
siderations. For each molecule of 1,3-diphosphoglycerate conve:cted 
to DFG :cather than directly to 3-phosphoglycerate via the phospho-
glycerate kinase reaction, an ATP is not formed. This effectively 
accomplishes the uncoupling of a subst:cate level phosphorylation. 
Du:cing storage of human blood under blood bank conditions, 
there is a progressive decrease in DPG, Hith the change being most 
rapid dm:·ing the first two Heeks of storage. Transfusion of blood 
so stored does not appreciably improve the delive:cy of oxygen to 
the tissues, since in the virtual absence of DFG, the hemoglobin 
in the transfused blood has a high affinity for oxygen. Upon re-
turn to the circulation, the cell DPG is quickly restored, with at 
least 25% of the final level being achieved within three hou:cs and 
··' 10 
more than 5076 Hi thin 24 hours (!aleri and Hirsch, 1969). It :nay 
take several days for the DIG lc:vel to return to normal, with the 
£i'lal level being that of the r~cipient. The rate of restoration 
ani. the final level are dependert on the quality and quantity of 
the preserved cells as well as the condition of the recipient 
(Beutler and Hood, 1969; BroennJe, Tung, Buchman and I.aver, 1970). 
Tne short-term benefits to a recipient would be improved 
considerably if cells with normal oxygen transport function were 
administered. It has been found that the DFG level of stored cells 
may be increased ill_ vitro from essentially zero to normal in JO 
minutes by an incubJtion with inosine (10 mM), phosphate (50 mN) 
and pyruvate (10 mM). Ihosphorylated intermediates arising from 
the meta.boJ.ism of the ribose moiety of inosine (Bartlett and Buccula, 
1965) become available for the formation of .DIG, while phosphate 
acts as a substrate in kinase reactions and pyruvate, via the lac-
tate dehydrogenase reaction, maintains adequate levels of NAD to 
relieve the NADH inhibition of glyceraldehyde-J-phosphate dehydro-
genase (I.Ici1anus and Borgese, 1961). In fact, the DFG level can be 
increased to several times the normal level by prolonging the in-
cubation for several hours (Duhm, Deuticke and Gerlach, 1971). 
The maximal level attained is probably limited by restrictions on 
the ability to synthesize rather than by an increased rate of de-
composition (Deuticke, Duhm and Dierkesmann, 1971). 
11 
.Q,Qntrol o-f DPG Netabolism ,_ 
There are a nwn_ber of factors which influence thE: metabolism 
of DfG. The spontaneous ,Jiminution of DFG in vitro i.s enhanced :Ln 
the presence of dithionitE, sulfite and disulfite (5 mM) (Gerlach, 
Duhm and DeuUcke, 1970; Mania and Varady, 1956; Gardos, 1966; 
Parker, 1969). This is thought to be a consequence of the acti-
vation of DFG phosphatase by these compounds, 'I'et;ra thioni te, 
thiosulfate and sulfate at 5 mivl inhibit DFG Jlhosphatase such that 
they almost completely abolish the normal decrease of DIG concen-
tration. 'This observation relative to sulfate provides a possible 
explanation of the observed clinical phenomenon that patients Nith 
renal incufficiency or uremia exhi_bi t inc:ceased levels of DFG in 
their red cells (Hurt and Chanutin, 1964). The plasma levels of 
sulfate achieved in these concli tions is in the range shmm to in-
hibit DIG phosphatase. 
In a general sense, the level of DPG can be affected either 
by changes in its rate of synthesis or breakdoNn. The rate of 
synthesis depends on the concentrations of precursors. The level 
of the p:cecursor 1,3-diphosphoglycerate, in turn, depends on its 
rates of synthesis and breakdown. Control of the rate of synthesis 
of 1,J-diphosphog1ycerate depends largely on the rate of the glyceral-
dehyde-J-phosphate dehydrogenase reaction, Nhich depends on the con-
centration of glyceraldehyde-J-phosphate, NAD and i_norganic phos-
Phate. It folloNs that increases in 1,J-diphosphoglycerate and 
12 
subsequently DR; can be obtained under conditions fostering high 
levels of glyceraJ dehyde-3-phosphate, NAD and inor,::;anic phosphate, 
such as are found in the incubation with inosine, j)yruvate and 
inorganic phosphate <Deuticke, Duhm and Dierkesman:-1, 1971; 
Deuticke and Duhrn, 1971). 
The formation of DR; is one of the hw alternatives for 
the catabolism of 1,)-diphosphoglycerate. Factors affecting the 
other alternative, the formation of 3-phosphoglycerate in the 
phosphoglycerate kinase reaction, will therefore affect the rate 
of formation of DIG. The reactants of the I;hosphoglycerate kinase 
reaction, ADP, ATP and 3-phosphoglycerate, therc;fore influence 
DIG production (Cerl<cch, Duhrn and Deuticke, 1970; Duhm, Deuticke 
and Cer lach, l 968; Duhm, Deuticke and Gerlach, 1969). 
Figur·e l shaHs the normal pa Unmy of glycolysis and DIG 
metabolism. Fig·ure 2 shoHs the sites of action of some other 
factors influencing DR; formation and decomposition. 
DR; synthesis increases as the pH values increase (Asakura, 
Sato, Minaimmi ar1d Yoshikavra, 1966; Astrup, 1970; Rapoport and 
Luebring, :1952). This is due directly to the influence of the pH 
on the activity of DIG mutase and indirectly to the increased 1,3-
diphosphoglycerate levels brought about by the JlH induced stimu-
lation of glycolysis. 
The accelerating effect of 3-phosphoglycerate on DPG syn-
thesis is of minor importance under physiological conditions, since 
such changes are small (Rapoport and Luebring, :1952; Ro;:;e, 1970). 
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Figure 1. The normal pathHay of glycolysis and DIG metabolism. 
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3-Phosphoglycerate 
Sulfate 
Tetrathionate 
l~'igure 2. 'Ihe site of action of some factors influencing DI--G 
formation and decomposition. 
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Since DFG itself inhibits DFG mutase, DFG is a controlling 
factor in its oHn synthesis. A relief of product inhibition at 
lo1.,r DFG levels results in increa.sed synthesis. 
3-Ihosphoglycerate and pi play antagonistic roles Hith 
rer,ard to the decomposition of DIG; an increase in the former 
i11hibits DFG phosphatase Hhile a decrease in the latter leads to 
i\:.3 activation (Ger1ach and Du.l-un, 19?1). 
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Involvement of Hormones Hith Red Cell Funct.lon. 
Tne capacity for release of oxygen f:rom hemoglobin is 
altered in a variety of condi tj_ons characte:...'iZed by an imbalance 
betvreen oxygen supply and demand. Among such disorders are mal-
functions of the thyroid gland. In thyrotoxicosis, a decrease in 
the affini.ty of hemoglobin for oxygen is reflected by a shift of 
the hemoglobin·-oxygen dissociation curve to the right (:Hiller, 
Delivoria-Pc,padopoulos, Jvl:Lller and Oski, 19'?0; Gahlenbeck and 
Bartels, 1968). Conversely, in hypothyroidism oxygen affinity is 
increased, and a shift of the dissociation curve to the left is 
seen (Grosz and Farmer, 1969) . 
DPG changes adequate to explain the changes in hemoglobin-
oxygen affinity have been reported in both spontaneously occurring 
and induced thyrotoxicosis (Hiller, Delivoria--:Papadopoulos, Miller 
and Oski, 1970). This adaptive mechanism would obviously be of 
advantage in that, in thyrotoxicosis where the oxygen demands of 
the tissues are increased, an increase in the P50 could provide 
an additional j_ncrement of oxygen to the tissues up to 40% of the 
pre-existing oxygen consumption (Miller, Sugarman, Miller, Delivoria-
P2,padopoulos, Diaco, Gottlieb and Osid, 1970). This is done without 
compromising the importance of respiratory and cardiac compensations 
for increased oxygen demands; one more facet to the optimal provision 
for oxygen needs is simply added. 
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'Jhe mechanism by rlhich the DFG level is increased in thyro-
toxicosis is still the subject of somH question. In the event of 
tissue hypoxia due to the disease, the: signal for increased pro-
duction of DFG may be no different frPm that in hypoxia due to 
anemia, atelectasis, high altitude, or any other reason. Snyder 
and Rc:;ddy (1970;1970a) have reported. a dlrect effect on the con-
centration of DIC in the red cell by thyroid hormone. They found 
an increase in DIG when Hhole cells Here suspended in buffer (Snyder, 
Neri, Chung, Jl1olinari and Reddy, 1971) or plasma as Hell as in a 
crude preparation of cliphosphoglycerate mutase from hemolysate in 
the presence of its substrate. They also prepared a purified. DPG 
mutase Hhich gave increased levels of DPG Hhen incubated Hith T4, 
T or 3,5-diiodothyronine. 3 
I1iller et al (I1iller, Svgarman, Niller, Delivoria-Papadopoulos, 
Diaco, Gottlieb a.nd Oski, 1970) report that T3 levels outside the 
physiologic range and much higher than those reported by Snyder and 
Reddy produced a significant increment in DFG Hhen incubated Hith 
fresh blood. They found no increase in DFG when a suspension of 
red cells in buffer Has used. 
others have commented (Schussler and Ranney, 1971) that they 
found. it surprising that the addition of autologous plasma failed 
to diminish the response of Hhole red cells to T3 , noting that they 
Hould have expected the thyroid--binding proteins in plasma. to reduce 
the available effective level of T
3
. They also questioned the un-
expected efficacy of 3,5-diiodothyroninc, Hhich has relatively weak 
hormonal activity. 
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J,nother group found that DFG bvels in the erythrocytes of 
rats tna ted Hith TJ did not change ( Duhm, Deuticke and Gerlach, 
1969). Noting their conflict Hi th Sr1yder and Reddy, these Harkers 
did furiher Hork Hith human red cells i~ vitro and rat cells in 
vivo and still fou..Yld no response to TJ or T4 (Gerlach and Duhm, 1971). 
Factors other tb2-n thyroid honwnes and DPG are believed 
to be ir vol ved in the process of facilitation of oxygen doli very 
under stress. One study showed that there were changes in P50 
across the ischemic cardiac tissue in a.ngina pectoris which Here 
apparently not mediated by DFG (Shappel, Hurray, Nasser, Wills, 
Torrance and Lenfant, 1970). 'Ihese authors speculated a.bout the 
possible involvement of catecholamines or cortisone in the process. 
Interest in the role of the adrenal hormones aldosterone 
and cortisol in the promotion of oxygen delivery has also been 
shoHn (Bauer and Rathschlag-Schaefer, 1968). There are findings 
to indicate that increased aldosterone levels are related to a 
decreased oxygen affinity of the blood in a nu.t'Uber of pathological 
conditions including mitral valve failure, myocardial infarction, 
experimental stenosis of the pulmonary artery and cirrhosis (Arora, 
1965; Coppage, Island, Cooner and I,iddle, 1962; Davis, 1962; 
Luetscher, DoHdy, Callaghan and Cohn, 1962; Jl1orse, Cassels and 
Holder, 1950; Nulhausen, Astrup and Kjeldsen, 1967; Wolf'f', Koczcorek, 
Buchborn and Kohler, 1956; Vlolff, Lommer, Jahnecke and Torbica, 1964). 
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ArJ impairment of the oxygen sup:)ly to the tissues is to be reCJ.son-
atly expected in these diseases and an :increase in P50 would help 
co~pensate for such a deficiet. Tissues have a great demand for 
oxygen under some condi-tions in rll:ich large quanti ties of cortisol 
are released, such as during the stress of strenous muscular per-
formance (Staeheli.n, Iabhart, Froesch and Kagi, 1955). No direct 
influence of aldosterone or cor1,i.sol has been found in such c ::mdi tions. 
Another compound found to influence the hemoglobin-oxygen 
dissociation curve is propranolol, vrhich is a highly selective 
beta adrenergic blocking agent, ·but has other apparently unrelated 
activities. Such characteristics as abolishing cardiac arrhythmias 
and stabiliz,ing erythrocytes aga:i.nst osmotic lysis are thought to 
be unrelated to beta blockade activity because 1) the dose for 
these effects is larger than is required for beta blockade, and 
2) d-propranolol, which is not a beta blocker, is as effective as 
d, 1-propranolol (Lucchesi, 1964-; Standaert, Levitt, Roberts and 
Raines, 1969). 
Propranolol shifts the in vitro hemoglobi.n-oxygen dissocia-
tion curve of fresh red cells to the right. It is thought unlikely 
that this occurs as the result of a direct effect on hemoglobin, 
since a dialyzed hemoglobin solution Has unaffected by propranolol. 
Since propranolol bas no effect on DIG, it is unclear how its in-
fluence is exerted. One hypothesis has it that the primary action 
of the drug is on the cell membrane. This is based on the essentially 
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instantaneous response of the P50 to propranolol as we~l as the 
morphological changes whi::::h are induced. Propranolol (_oes not 
shift the dissociation curve of outdated red cells, whJ_ch still 
have intact membranes. T1is suggests that there may bE a dependence 
on cellv_lar metabolism (Pendleton, Newman, Sherman, Brann and Naya, 
1972). 
A report on the in vivo changes inducecl by propranolol 
builds on the previous observation that P50 is shifted Hith no 
change in the level of DR::. Oski et al found that uncler normal 
conditions, about 30% of the ny,_; in the cell was bound to the 
membrane. Upon incubation with propranolol, the bound DIG was 
released. They offer this report in the context that "'fue presence 
of adenosine triphosphate that is bound to the red cell membrane 
has been deriionstrated." ( Oski, Miller, De1ivoria-fupaclopoulos, 
Manchester and Shelburne, 1972) This turns out to be only nomi-
nally the case. Tne paper to which they refer (L-'lCelle, 1970) 
has to do with the deformability of the red cell membrane, and 
offers a model for a mechanism resulting in rigidity of the mem-
brane due to the interactions that ATP, as well as some other 
compounds, have with some membrane proteins at the inner membrane 
surface. Apparently any binding which occurs is not too strong, 
since changes in deformability of the membrane v;hich are charac-
teristic of A'I'P deficiency were observed when cellular A'I'P Has still 
70% of its initial value. No indication was given of Hhat fraction 
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of cellular ATP was c,ssociated Hith the supernate 3..nd stroma 
in a hewolysate. An interesting hormonal effect i3 the reported 
finding by Oski et a] that epinephrine blocks the "releasing" action 
of propranolol (Oski, Hiller, Delivoria-IJapadopoul0s, Jl1anchester 
and Shelburne, 1972). It was not ascertained whether the shift in 
P 50 due to propranolol s·Lill oc:curred in the presence of epinephrine. 
It 1wuld be presumed that it does not, since it is app:1rcmtly pre-
sumed that the shift is mediated by DIC. 'Ihe change in DPG is 
theoretically sufficient to account for -t.he observed changes in 
P50 due to pro1)ranolol. 
If accepted at face value, this work is significant in that 
it explains the means by Hhich pr0pranolol ;:-,,ffects the P50 vii th-
out changing cell ulal· DIG content. Also it shows an interesting 
involvement of epineJ)hrine in the red cell. 
An understanding of the relationship between red cells and 
hormonal substances is made more difficult by Uw reJ10I't (Allen and 
Rasmussen, 1971) that epinephrine, as well as the hormonal substance 
prostaglandin E2 ancl isoprote:r·enol, decrease de formability. 'Ihese 
observations Here directly contradicted by Jay et al (Jay, Rowlands 
and Skibo, 1973) who f01.md that none of the~e compounds affected 
deformability. 
In 1970, (Nikikits, Hortara and Spector, 1970) it was re-
ported that epinephrine as well as a number of other compounds, had 
anti-hemolytic action, while propranolol exhibited no membrane 
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protecting eL'ect. This was folloHed by a subsequent report 
(Roth and Seenan, 1971) that epinephrine had no significant 
protective ef:'ect on erythrocytes Hhile pr-1p.ranolol Has judged 
very effectivn. A subsequent paper (Olaisen and ¢Ye, 1973) con-
f:irmed the opinion that propranolol Has indeed effective at pro-
tecting red cells from hypotonic hemolysis. 
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The Proposed S~ud~ 
There is considerable controversy ovE·r the effects of thy-
roid hormones, co::ctisone, aldosterone, cort:;.:::;ol, prostaglandin E2 , 
and epinephrine on DFG levels. Perhal)S the most involved reports 
of hormone eff octs on DFG relate to the effE·cts of the thyroid hor-
mones T3 and T4 . In these instances, the reports purport to show 
the effect and the mechanism. In spite of the fact that thec-;e 
explanations a:.ce quite reasonable, from a fllnctional perspective, 
there are those Hho question whether such effects in fact do exist, 
and if so under Hhat conditions may they be demonstrated. 
There is considerable interaction between the functioning 
of the thyro.id. and adrenal glands, rdth thyroid function decreasing 
in normal huinans under the administration o:f epinephrine, ACTH or 
cortisone. Changes in the levels of adrenal hormones have also 
been found in thyrotoxicosis and myxedema. Adrenal hormones, epi-
nephrine in particular, are Hell known to be elaborated in response 
to stress. 
The knowledge that adrenal and thyroid hormones respond to 
stress and the conflicting views on the involvement of these hor-
mones in red cell metabolism and function Jed us to investigate 
the effect of these hormones on the level of DFG in red cells. 
Apart from the involvement of hormones and vasoactive sub-
stances in oxygen delivery via changes in DPG levels, the larger 
question of modulation of red cell function via membrane interactions 
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has been raised. This involves modulatj_on of DFG binding to the 
membrane and the structural integrity of the ce1l itself. We 
Hill investigate both of these phenosena. 
Epinephrine is unique in that it. is found to be mentioned 
HHh respect to every :p..'lrarneter considered here--general physio-
logical ;,_'esponsc to stress, effect on DIG level, and membrane 
effect on red cells. These diverse involvements make this com-
pound of partjcular interest. 
\ 
HA TERIA~B AND NETHODS 
1'1~ TERIALS 
R8d Blood Cells - Blood was taken from volunteers by venipuncture 
and collected in heparinized vacutainers. Tne blood ;ms 
centrifuged for 10 minutes at JOOO PJ111 1 and the plasm:1 
and buf'fy coat were reme>ved from the packed red cells Hi th 
the use of a pipet and rubber bulb. 
-~inephrine - Sigma Chemical Company 1 #E-4250 1 J.,ot J1C-2990. 
Propranolol - Sigma Chemical Company 1 #P-088'-r 1 Lot 82C·-2110. 
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HF~THODS 
Incubation of Red Cnlls With Adrenal Hormones. 
The red cell;:; were suspended in fortified Krebs Ringer-
Bicarbonate to a heJ.1atocri t of JO. Forty microlj ters of the 
appropriate hormone solution were added to 4.0 ml aliquots of 
tbe cell suspension in 25 ml Erlenmeyer flasks Hhich were closed 
by rubber stoppers Hbich had been punctured by hio 21 gauge 
needles, with one opening near the to1; of the flask and the other 
near the surface of the solution. The flasks >-rere flushed for 
JO seconds with a mixture of 5% co2/rolance air, and subsequent 
incubation at 37° C w-as carried out under a slow- continuous flow-
of the gas mixture through the flask, entering near the surface 
of the solution and exitj_ng from the top of the flask. Ten 
microliter samples Here taken at JO minute intervals and placed 
in tubes, each containi:r..g 5 ml of 5. 0 ml1 NaOH, for DFG analysis . 
Each flask was again flushed w-ith the gas mixture after the taking 
of each sample. The entire incubation w-as carried out Hith shaking 
at 60 cycles per minute in a water bath (Blue M Electric Company, 
Magni Whirl, Hodel RSB-1120A). 
Reagents for adrenal hormone incubations. 
Krebs Ringer-Bicarbonate - 100 ml of 0.9% NaCl, 4 ml of 
1.15% KCl, J ml of 1.22% CaCl2 , 1 ml of 2.11% IDi2Po4 , 
1 ml of J.82% Y~so4 ·7 H20, and 21 ml of 1.20% NaHCOJ 
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were mixed. A mixture of 5% co2/bal~nce air was bubbled 
through the solution for 1 hour. Tne solution was stored 
under refrigeration in a ground glas..> stoppered bottle. 
Fortif:~ed Krebs R1ngq_r-Bicarbonate - 19.6 ml of Krebs 
Ringer-bicarbonate, 200 microliters of glucose (17.8 mg/ml) 
and 200 microliters of potassium phosphate (0.3 H, pH 7.4) 
were mixed. This resulted in a solution that was 4 mH in 
glucost.' and 3 ml1 in phosphate. 
Corticosterone- 1 mg corticosterone (Sigma Chemical Co., 
#D-2505, Lot 108B-2970) was dissolved in 0.5 ml of abso-
lute ethanol and 9.5 ml vrater wel'e added. Ten microliters 
of appropriately diluted solution Here w:;ecl per ml cell 
suspension. The normal free plasma level is 100 ng per 
100 ml. T.t1is solution contained 1. ng per 10 microliters, 
vrhich was enough to make the suspension 1000 times the 
normal level with the amounts used. Serial ten fold 
dilutions were made for other hormone levels. 
Cortisol - 5 mg cortisol (Sigma Chemical Co. , //H-4001, 
I1ot 120C-1410) were dissolved in 0.5 ml of absolute etha-
nol and 4.5 ml water were added. Ten microliters of ap-
propriately diluted solution vmre used per ml cell suspen-
sion. Tne normal free plasma level is 1000 ng per 100 ml. 
Tnis solution contained cortisol sufficient to make the suspen-
sion 1000 times the normal level vrith the amounts used. Serial 
ten fo1d di1utions were made for other hormone levels. 
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Testosterone- 1.2 mg of test:Jsterone (Sigma Chemical 
Co., #T-1500, Lot JBB-1100) w·~re dissolved in 0.5 ml of 
:tbsolute ethanol and 9.5 ml of Hater were added. Ten 
microliters of appropriately diluted solution were used 
per ml cel1 su.spension. Norma.l free p1asma levels are 
JO to 1200 ng per :lOO ml. Th:· s solution contained testos-
!:,erone sufficient to make the suspension 1000 times the 
normal level. Serial 10 fold. dilutions were made for 
other hormone levels. 
Epinephrine - Two mg of epinephrine Here dissolved in 
20 ml of 0.01 N HCl. Ten microliters of appropriately 
diluted so1ution were used per ml sus})ension. The normal 
free plasma level is 1 1:1icrogra.m per liter. 'rhis solution 
contained enough epinephrine to make the suspension 1000 
times the normal level with the amounts used. Serial ten 
fold dilutions were made for other hormone levels. 
Method for the Assay of 2,_J-Di phosphol)l,y_cerate (DIG)_. 
Tne assay method used was a modification of the automated 
method of Atkinson (Atkinson, 1972). Since DIG is a cofactor in 
the enzymatic conversion of J-phosphoglycerate to 2-phosphoglycerate, 
the rate of this conversion is dependent on the concentration of 
DFG. The 2-phosphoglycerate formed may in turn be converted to 
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phosph•)-enol-pyruvate and pyruvate u1der the action of the enzymec· 
enolasE: and pyruvate kinase, respect.Lvely. The pyruvate may then 
be rea-;ted Hith 2,4-dinitrophenylhydrazine to form the phenyl-
hydrazone, vJhose concentration may be determined by measuring the 
absorbance at l.fjO nm. Tnis reaction sequence is shovm in figure J. 
Th~s chemistry Has adapted to an AutoAna1yzer I (Technicon 
Corporation, Tarrytmm, Ne1·r York) system Hhich included a Sampler II, 
0 a Pump I, a 37 C water bath, a single channel colorimeter and a 
strip chart recorder. 'Ihe floH diagram is shown in figure 4. 
vlhen the procedure as described by Atkinson vras put into 
operation, two prol)lems were immediately evident. First, the blank 
absorbance Has too high, producing a deflection of the order of one 
half of full scale. Secondly, the res110nse to a set of standards 
ranging from 2 to 10 nmol DPC per ml was too e;reat, resulting in a 
standard curve Hhich reached a plateau, and also resulting in a poor 
separation behreen the peaks on the strip chart, a condition Hhich 
is usually called "poor Hash out." This situation was unsatisfactory 
for the following reasons: 
1. The only Hay to reset the reagent baseline to zero 
vras to decrease the output of the reference photo-
cell in the colorimeter by using a smaller aperture. 
This resulted in an unacceptably loH energy level. 
2. The ability to distinguish between samples containing 
more than 4 nmol per ml of DFG was insufficient. 
Phosphoglycerate mutase )-Phosphoglycerate --------~~--~~~--~----------~~2-Phosphoglycerate DFG 
Enolase 2-Phosphoglycerate--------------------~~ Phospho-enol-pyruvate 
Pyruvate kinase Phospho-enol-pyruvate ______ _.....!·'------------~ Pyr:....va-~e 
Pyruvate + 2, 4-Dini tropheny lhydraz ine --------------;.. 2 , 4-Dini tropheny lhydraz one 
A = 4t::.O Dill 
max ./ 
Figure J. The reaction sequence utilized in DPG assay method. 
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Tne data obt2.ined from the analysis of a set of standards under 
these conditions follows: 
2 nmol DIC/ml 28 . 5% Transmittance 
4 " " 1J.O% " 
6 " " 8.0% " 
8 " " 6.5% " 
10 " " 5.5% " 
It was foUt'1d that by using the wavelength of 550 nm rather 
than 450 nm, the absorb:1nce of the chromophore was reduced by 
about half (A550 m/A450 nm == 53%) and the absorbance of the 
reagent baseline could be reduced by about hw thirds (A / 550 nm 
Tnis was seen as the best solution to the probJem 
of excessive sensitivity. In order to decreat:;e the sensitivity 
further as well as to increase the ;;;ep:=1.ra t:i..on betv1een samples, 
the sample to trash ratio, vrhich was recommended to be 60 per hour 
at 2:1, was changed to 60 per hour at 1:1. This achieved the 
introduction of less DFG into the system for each sample and a 
longer wash time betHeen samples. 
Another problem which was appan:nt was that the baseline 
absorbance increased throughout the run at a rate much too high 
to give good results, reaching 60% of full scale in a 50 minute 
run. Once achieved, this high absorbance was not reduced by sub-
sequent water flow through the system. Flushing the flow cell in 
the colorimeter with ethanol removed the absorbing material, Hhich 
was thought to have accumulated as a consequence of the wetting 
·-· 
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agent, Triton X-10·), which rras present at the recommended level of 
0.1% in the Hash we,ter. Qnission of this compound from the reagent 
alleviated the pro 1>lem. 
By incorporating these three modification0--1) changing 
the wavelength from I-JjO nm to 550 run, 2) changinG the sample :Hash 
ratio from 2:1 to 1:1, and 3)eliminating the vretting agent--much 
more satisfactory results were obtained. A typir;al standard curve 
is shmm in figure 5. 
At the level of 6 nmol/ml, this system operated at 77% of 
steady state. Samples of blood or cell suspensions to l)e analyzed 
consisted of :lO microliters of sample added to 5.0 ml of 5 mM NaOH. 
The DR; was stable in this alkaline solution for several hours at 
room temperature. 
Reagents for DPG assay method. 
2,4-Dinitrophenylhydre,zine - 250 mg of 2,4-dinitrophenyl-
hydrazine (Sigma Chemical Co., #D-2630, Lot i:lC-2710) Here 
dissolved in 1 liter of 1 M HCl. 
Sodi1~ Hydroxide - 40 g NaOH Here dissolved and diluted 
to 1 liter. 
Ethylenediamine Tetraacetic Acid, 0.12 M - 40.3 g of 
ethylenediamine tetraacetic acid (EDTA) (Sigma Chemical Co., 
#ED1SS, Disodium salt, Lot lt-2C-3120) rrere dissolved in 800 ml 
water. Tne pH was adjusted to 7. 3 with 2 11 KOH and the volume 
was brought to 1 liter. 
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Figure 5. Standard curve for the modified automated DFG method. 
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Ethylen(~cliamine Tetraacetic Acid 1 0. Q.S li - 250 m1 of 
0.12 H };DTA were diluted Nith 250 ml vmter. 
EnZ:J'lT!e \}ixtu:re - To 4-0 ml of water co"1taining 50 mg of 
bovine <::.1 bumin, Fraction V, 0. 65 ml ( 1800 units) pyruvate 
kinase suspension (SigrEa Chemical Co. #P-1381, I1ot 42C-9520), 
12.5 microliters (?5 units) of phosrJhoglycerate mutase (Sigma 
Chemical Co. ffP-8252, Lot 61C-99+0), and 10.6 mg (500 units) 
enolase (Sigma Chemical Co. #E-6126, Lot 51C-856J) Here added. 
The volume v<as brought to 50 ml with vmter and the mixture 
was frozen in J ml aliquots. 
Tris-H10sphate Bu£fer - 60.5 g Trizma Base (Sigma Chemical Co. 
1/T-1503, Lot 92C-5010) and 68 g EJI2Po4 (NallinclrJodt #7100, 
Lot XTP) Here dissolved in 800 ml water. The pH 1-ms brought 
to ?.J Hith concentrated HCl, and water was added to 1 liter. 
T1gC1 2 - 20 .J g of 11gCl 2 · 6 H20 (Nallinckrodt 115958, Lot NRH) 
Here dissolved and brought to 100 ml Hith water. 
J-Fhospho_tslycerate - 14.3 g of barium salt of J-phosphoglycerate 
(Boehringer-Mannheim, Kontroll #71JOJ2Li-) Here sloHly added to 
20 ml of Hater while stirring, to make a milky Hhite suspension 
rrhich Has stirred for 10 minutes. Eight ml of 10 N H2so4 1fere 
added and the mixtlrre Has stirred for an additional JO minutes. 
Tne suspension Has centrifuged for 5 minutes at JOOO RPll1. 'Ihe 
precipitate vras Hashed twice with 25 ml portions of water, 
which were pooled rrith the supernate and brought to 200 ml. 
'.:·II' I 
:11,1 
11'!1 :li 
11:11 
,11
1
11.: 
I'!' ~~.~~~ 1',1 :;II, 
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'Ihe pf Has adjusted to 1.86 with co1centrated NaOH, and 
the sclution was passed through a c;)lumn filled Hith Dovwx-1 
(Sigma Chemical Co. #P-82_52, Lot 61C-9_540) at a rate of 3 
drops per minute in the cold room (.1-° C). The pH was ad-
justed to 7.3 Hith 'I'ris base and the solution was frozen 
.in _50 ml aliq_uots. 
AdenoEine Dlphosphate - 1.07 g of disodium salt of 
adenosine-.5'-diphosphate (Sigma Chemical Co. #A-0127, 
Lot 22C-7_590) dissolved and brought to 2.5 ml. 
:::c.S..;;;;u;.::::.b;;;:.st.::.;r=...a:.;_t.::..:q_- 200 ml of Tris-pho~>phate buffer, _50 ml of 0.06 N 
EDTA, 7._5 ml J.1gCl2 , _50 ml 3-phosphoglycerate and 2.5 ml of 
adenosine diphosphate vrere mixed and diluted to _500 ml 
vd th water. This reagent vms frozen at -30° C in 20 ml 
aliq_uots. 
Enzyme-Substrate Nixture - 3 ml of enzyme mixture and 20 ml 
of substrate Here mixed and diluted to _50 ml with cold water. 
The mixture was chilled in an ice bath for 1.5 minutes before 
use. 
5 mM Na0£l - 200 mg NaOH were dissolved and diluted to 1 liter. 
2,3-Diphosphoglycerate Standard~ - 42.9 mg of 2,3-diphospho-
glycerate (DFG) (Pentacyclohexylammonium salt, Sigma Chemical 
Co. #D-6006, Lot 81C-3290) were dissolved in 2 ml water and 
diluted to 200 ml rrith .5 mM NaOH. This stock was diluted 
II 
37 
with 5 ml'1 NaOH as follo m for Harking standards: 
Nicroliters Stock 1~'inal Volume DR; Concentr2tion 
80 10.0 ml 2 nrnol/ml 
200 12.6 ml 
'+ 
.II 
300 12.6 ml 6 II 
400 12.5 ml 8 II 
500 12.5 m1 10 II 
DB:; ~inding ExJ2eriments. 
Red cells were suspended in buffer to a hematocrit of 62. 
For those tubes in which 1:1 hemolysates were to be made, 9.7 ml 
of the suspension were added; for those tubes in vrhich 1:10 
hemolysates were to be made, 1.8 ml of suspension Here added. 
All these tubes Nere centrifuged for 5 minutes at 3000 I\I-11, and 
the supernates Here decanted. To make 1:1 hemolysates, an eq_ual 
volume (6 ml) of water was added; to make 1:10 hemolysates, 11 ml 
of Hater Here added. All tubes vrere mixed by inversion and allowed 
to stand for 10 minutes. They were then centrifuged for 15 minutes 
at 3000 RPM, after which the stroma fraction was visibly opaque in 
the 1:10 hemolysates. The 1:1 hemolysates were too dark to tell 
Nhether there Has an opaque layer due to stroma. For these hemolysates, 
the best Hay to ascertain stroma content Has to make a smear on a 
slide and observe directly under phase microscopy (100 X magnifi-
cation). Following centrifugation, the contents of the tubes were 
divided into sections by taking off aliq_uots of approximately 2 ml 
I 
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each with a pipet and suction bulb starting from the te>p of the 
tubes. 
In order to deten,ine the effects of propranolol and epi-
nephrine on binding, the~e compo1.mds v;ere added to the isotonic 
cell s~pension and incubated at room temperature for 20 minutes 
before the cells Here separated and the hemolysate made by the 
addition of water. 
Reagents for the binding experiments. 
Isotonic Buffer - Solutions of NaH2POL~ ( 6. 9 g/li ter) and 
Na
2
HP04 (7.1 g/liter) were mixed to pH 7.0, and 100 ml of 
this mixture were added to 900 ml of a solution containing 
8. 57 g NaCl, 373 mg KCl, :l.I,L7 mg CaC12 , 2L~7 mg NgS04 and 
2.0 g glucose. 
Propranolol - 5.9 mg of propranolol dissolved in 2 ml Hater. 
Ten microliters ~ed per 3 ml of cell suspension for a final 
concentration of 3.3 x 10-5M. 
Epinephrine_ - 5.4 mg of epinephrine were dissolved in 3 ml 
of 0. 01 N HCl. Ten microliters Here u,sed per 3 ml cell 
suspension for a final concentro,Uon of 3. 3 x 10-5 11. 
Hemoglobin Assay F-rocedur~ 
Hemoglobin was assayed by the cyanomethemoglobin method 
(Kachmar, 1970). This was accomplished by the addition of 20 micro-
liters of the solution to be analyzed to 5.0 ml of cyanomethemoglo-
bin reagent, mixing, and al.lowing a 20 minute incubation at room 
temperature before reading the absorbance at 540 nm. 
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1. 0, 2. 0, 3. 0, 4. 0 and 5. 0 ml aliguots of a standard 
cyanomethemoglobin solution were diluted to 5. 0 ml wi-~h cyano-
methemoglobin reagent. These represent concentration:> of l+, 8, 
12, 16 and 20 g hemoglolin/100 ml blood, respectively. A stan-
clard curve Has constructed by plotting the a1)sorbance of each 
standard against its con::entration. Such a cvrve is <:,[w-vm in 
figure 6. 
Reagents for hemoglobin assay. 
Cyanomethemoglobin Reagent - 200 mg potassium ferricyanide, 
1.0 g N&HC0
3 
and 50 mg KCN Here dissolved and brought to 
1 liter. 
Hemoglobin Standard - Hycel #117 certified cyanomethemoglobin. 
guanti tati ve CeJ_l Cou_Ylt,. 
The quantitative cell counts Here obtained through the use 
of a Coulter Counter, ModelS (Coulter Electronics, Inc., Hialeah, 
Fla.), which is an instrument used in Clinical Hematology labora-
tories for that purpose. This instrument operates on the principle 
that changes in conductivity of a buffer solution occur, brought 
about by displacement of that buffer by suspended particles which 
come between the e1ectrodes. Thus particle size is a critical 
factor. The analyzer is programmed to classify particles according 
to the range Hithin Hhich their dimensions fall. A printed report 
is generated. 
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Figure 6. A cyanomethemoglobin standard curve. 
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Reagents for :luantitative cell count. 
Isoton Lc Sol uti on - 1. 42 g Na2HP04 c:.nd 8. 47 g NaCl were 
dissolved in 900 ml Hater. The pH .,,as adjusted to 7 .J 
Hi th c.ttric acid and the volmne was brought to 1 liter. 
lJ-1 
This solution Has 10 mH in phosphate and 1'-~5 miV! in NaCl. 
_Ijy£otonic Solution - 1.4-2 g of Na2HP04 and 2. 92 g NaCl 
were dissolved in 900 ml Hater. ThE pH Has adjusted to 
7.3 with citric acid and the volume Has brought to 1 liter. 
This solution vias 10 mH in phosphate and 50 mM in NaCl. 
Protection Againsj:. _ _u_emo1ysis by Propranolol. 
Red cells Here suspended in isotonic solution to a hemato-
cri t of 4. 5. 0 .1+ ml of the suspension was added to 6.1 ml of 
hypotonic solution which contained the appropriate amount of pro-
pranolol and epinephrine, vrhere indicated. 'Ihe hemolysates Here 
centrifuged for 5 minutes at JOOO RI11. The supernates vrere de-
canted and the absorbance at 543 nrn Has measured. Tne percent 
hemolysis was determined by the formula: 
Absorbance5'+3 nm in hypotonic 
percent hemolysis Absorbance543 nrn in Hater 
X 100 
The relative hemolysis WdS defined as: 
1 t . h 1 . %hemolyzed Hith drug re a lYe emo ysls == % h 1 d o emo yze Hitbout drug X 100 
L 
·.• 
Reagen i-.s for experiments shmdng p:rc·tection against hemolysis, 
Propranolol - 19.23 mg of propranolol were dissolved in 
61.0 ml of hypotonic solut2.on. This constituted 10-2 M 
propranolol. Serial 1 to 10 dilutions Here made Hith 
hypotonic solution for concentrations through 1 x 10-6 M. 
Epine_:chr:Lne - 18.3 mg of epinephrine Here dissolved in 
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10 ml of 0. 01 N HCl. Tn1s constltuted 10-2 M epinephrine. 
Further dilutions Here made a:; needed Hith hypotonic 
solution. 
Isotonic Sol uti on - 1. LJ.2 g Na2HP04 (to 10 m.N) and 8 .J.J-7 g 
NaCl (to 1L;j mN) Here dissolved in 900 ml Hater. Tne pH 
Has adjusted to 7.3 with citric acid and the volUi'lle Has 
brought to 1 liter. 
Hypotonic Solution - 1 .1-J-2 g of Na2HP04 (to 10 mM) and 
2.92 g NaCl (to 50 mM) were dissolved in 900 ml water. 'Ihe 
pH Has adjusted to 7.3 Hith citric acid and the volume was 
brought to 1 liter. 
Preincubation Experim~~ts 
In the preincubation experiments, sufficient epinephrine 
and propranolol Here added to the isotonic suspension such tha.t 
the final concentrations of propranolol and epinephrine Here 
10-3 11 after the addition of 6.1 ml hypotonic solution to the 
0.4 ml of cells and drugs in isotonic solution. A 5 minute incu-
bation folloHed the addition of hypotonic solution, and then the 
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hcmo1ysates were centrifuged fer 5 minutes at 3000 RPM. The 
supernates were decanted and tne absor1Jance of hemoglobin at 
_543 nm was measured. 
Reagents for preincubation expel'iments. 
ProJ?r_?-nolol - 38.46 ng of propranolol were dissolved -i_n 
2 ml of isotonic soluticn. Hhen 100 microliters were 
used in the preincubaticn, the final concentration af-~er 
hemolysis was 10-3 N (6._5 x 10-2 M in isotonic preincubation). 
Epi~_phrine - 23.82 mg epinephrine vrere dissolvecl in 2 ml 
isoton:lc solution, Hith the addition of 1 drop of concen-
trated HC1 to aid solubilization. vlhen 100 microliters 
He:e used in the preincub-'ltion, the final concentration 
-3 
after hemolysis Has 10 H. 
Epj_n~chrine in Stoichiome"t_!_~c H.Cl - 23.82 mg of epinephrine 
(which eg_uals 0.13 mmol) Here dissolved in 2 ml of 0.065 N 
HCl (which eg_ uals 0 .13 v.r:wl). 100 microl:i. ters Here used 
per 6._5 ml final voluirre for 10-3 M. 
W&-shing of Cells Ere incubated l·r-i th ProJ!ranolol. 
These were experiments to determine Hhether the effect 
of propranolol would be dimi:r:.ir-,hed if the cells Hhich had been 
preincubated Nith propranolol in isotonic solution were washed 
with isotonic solution before hemolysis. This was to determine 
Hhether the reg_uired propranolol Hould be bound to the cell strong-
ly enough to resist being Hashed aHay. For these experiments, the 
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red cells Here suspended in isotonic solution to a henatocrit of 
40. THo hlmdred microliters of the cell suspension were mixed 
vri th 200 microliters of _propra.nolol and pre incubated for several 
minutes. The tubes Here then cen·trifuged at, JOOO Rl''M for 5 minut-es 
and the <mpernates Here decanted. For those cells not to be washed, 
6.1 rnl of hypotonic solu·~ion Here add.ed at this point. F'or those 
cells Hhich Here to be Ha .. shed, .5. 0 ml of isotonic solrtion Here 
added and the cells Nere resuspended, mixed gently, and then cen-
trifuged again for 5 minutes at JOOO RPIL Subsequent 1rashes were 
carried out in the sa~me manner. After the appropriate number of 
washes, 6 .1 ml of hypotonic sol utio11 vwre added to the tubes, the 
tubes Here allowed to incubate at room temperature for 5 minutes, 
and were then centrifuged. for 5 minutes at JOOO RPI1. The super-
nates Nere decanted and the absOJ:'bance at 543 run measured for the 
calculation of the percent hemolysis. 
Reagents for Hashing experiments. 
Isotonic Solution - 1.1-J-2 g Na2HP04 (to 10 mM) and 8 .L~? g 
NaCl (to 145 mH) v;ere dissolved in 900 ml Hater. 'Ihe pH 
was adjusted to ?.J Hith citric acid and the volume Has 
brought to 1 liter. 
Hypotonic Solution - 1.l.J·2 g of Na2HP04. (to 10 mN) and 
2.92 g NaC1 (to 50 mM) Here dissolved in 900 ml water. 'Ihe 
pH was adjusted to ?.J Hith citric acid and the volume was 
brought to 1 liter. 
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Propranolol - 29 . .58 mg of propranolol were dissolved in 
10 ml of isotonic solution, making this rEagent 10-2 M. 
Binding of :r..a.beled._ff,pinephrine to Red Cells. 
These experiments were desig.1ed to dC!termine the extent 
to which epinephrin-e was removed from solution by red cells. A 
solution of epinephcine, labeled Hith tritium, was prepared in 
4.5 
iE>otonic solution. Different amow'1tG of an isotonic cell suspen-
sian were added to ~ constant final volume in isotonic solution 
as indicated in T-able 1. A parallel series Has prepared in which 
a constant amount of propranolol Has Ilresent. After a 10 minute 
incubation at room temperature, the suspensions were centrifuged 
for .5 minutes at JOOO RPM and the radioactivity in the supernate 
was measured. The epinephrine dilnUon curve is the measured. 
radioactivity of 100 through .500 microliters of epinephrine solu-
tions, in 100 microliter increments, diluted to .5.0 ml. 
Reagents for studies of labeled epinephrine binding. 
Propranolol 29 . .58 mg propranolol were dissolved in 10 ml 
of isotonic solution, to make a 10-2 M reagent. 
Tritiated Epinenhrine - DL-Adrenaline-7-HJ (Amersham/ 
Searle TRA.217, 2.50 microcuries as aq_ueous solution, 14 x 106 
microcuries per mmol). Six hundredths of a microcurie 
(4.J x 10-9 mmol) of labeled adrenaline (i-n 0.2 microliters) 
were added to a solution of J6.6 mg epinephrine dissolved 
in 20 ml of 0.01 N HCl. The final concentration was 10-2 M 
epinephrine. 
..• 
Co1l Suspens.i~n, A 
100 
20G 
300 
400 
500 
600 
800 
1000 
1500 
100 
200 
300 
400 
500 
600 
800 
1000 
1500 
0 
0 
ml of 10-2 11 
Propranolol 
0 t' •:J 
-2 
ml of' 10 ~ 1'1 
-~~nephrine 
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ml Isotonic 
Solution 
4.4 
4.3 
4.2 
4.1 
4.0 
3.9 
3.7 
3.5 
3.0 
3.9 
3.8 
3.7 
3.6 
3.5 
3.4 
3.2 
3.0 
2.5 
4.0 
Table 1. Protocol for the experiment investigating the binding of 
labeled epinephrine to red cells. Final volume is 5.0 ml. 
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Isoton be Solution - 1.42 g Na2HP01+ 1: to 10 ml'I) and 8.47 g 
NaCl Co 1h_5 mN) Here dissolved. in 5)00 ml water. Tne pH 
Has adjusted to 7. 3 Hith citric aci,l and the volume Has 
brough~ to 1 liter. 
Incubation of Hed C~_ll S_l;J~~nsions Hi t_h 'IhY.Eoid Hormones. 
Hed co:Llr:> ·Here su::-,psnded in a mixture consisting of tvro 
thirds deprotl"in:i_zed_ plasma anci one third :Frebf:> Ringer-bicarbonate 
by volume to a hematocrit of 37. To '-r ml aliquots of the cell sus-
pension in 2.5 ml Erlenmeyer flasi;:.s fj_ttecl for gas floH, 10 micro-
liters of hormone solution Here adclPd and the flasks were incubated 
at 37° C Hith shaking under an atmosphere of ~% co2/balance air. 
Sam:ples Here taken at 1 hour intervais for analysis of DIG and 
glucose. 
Reagents for incuba.tion Hith thyroid hormones. 
'I'riiodothyronine (T3 ) - 24 1 ~. f t .. d th . •• -r mg o rllO o yronlne 
{3igma Cherdcal Co. #T-2877, Lot .51 C-2830) Here dissolved in 
1 liter of water Hith the a:"Ld of dilute NaOH as reg_uired for 
solubility. Ten microliters of this reagent diluted one to 
one Hi th Hater brought Lr ml of cells in suspension to 
-8 3.8 x 10 M in T
3
. 
Tetraiodothyronine (Thyroxine or ·r4 ) - JJ .J mg of T4 (L-
thyroxine, Sodium salt, Sigma Chemical Co. #T-2.501, Lot 71C-
2020) Here dissolved in 100 ml of absolute ethanol. For use, 
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this reagent was diluted Hitr an equal volume of water and 
10 microliters Here used per 4 ml of cell suspension. 
Deproteinized Plasma - Plasma Has placed in a boiling Ha +e:~ 
bath for 15 minutes. After cooling, the resulting gel >-Ias 
cut into c;mall pieces and centrifuged for 30 minutes at 
44,000 x G. The supernate Has decanted and frozen. 
Incubation of Hhole Blood Hi th Thyro:id Ho_rmone~. 
F'our ml aliq_ uots of whole blood were placed in 25 ml 
Erlenmeyer fJasks fitted for gas floH. Three hundred microliters 
of hormone solution Here added to the appropriate flasks and incu-
bation was carried out under a floH of 5?s co2/balance air at 37° C 
v<ith shaking at 60 cycles per minv.te in a Hater bath (Blue N 
Electric Company, Hagni1dhirl, 11od_el RSB-·1120A). Samples were 
taken at 1 hour intervals for DTC analysis. 
Reagents for incubation of Hhole blood with thyroid hormones. 
Triiodothyronine (T
3
) - 5.86 mg of T3 (3,3' ,5-T:ciiodo-
L-1'hyronine, Free Acid, Sigma Chemical Co. #T-2877, Lot 
51C-28JO) vmre dissolved in 100 ml of Hater Hith the aid 
of 2 drops of 1 N NaOH. 300 microliters were used per 
4 ml of Hhole blood for a final level of 4.1-¥ micrograms 
per ml blood. 
Incubation of Red Cel1s in Hodium for _DJ:-"G RegeneratiSJJl.:.. 
The red cells Here Hashed once Hith several volumes of 
inosine-phosphate-NaCl solution. Tne cells were then suspended 
to hematocrit 11 in the inosine-phosrJhate-NaCl solution and in-
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cuba ted at J7° C vd.th shaking for J hours. Tne cell suspen:oion 
vas divided into 1.5 ml aliquot3 and centrHuged for lO minutes 
a,t JOOO RP1'1. The supernate Ha3 decanted and the cells were 
vrashed three times Hith 10 ml -portions of J(rebs Ringer-bicarbo-
nate. Then 4 ml of f>Tebs Ringer-bicarbonate were added to each 
tube, brine;ing the hematocrit of each to 2J. 'lne suspensiors 
were transferred to 2.5 ml Erle lffieyer flasks fitted for gas flow, 
100 microliters of pyruvate rea.gent were added to each, and 
incubation for 60 minutes under .5% co2/baJance air lms carried 
out. Samples Here taken at the intervals indicated for DI'G analysis. 
Reagents for incubation in medium for DPC regeneration. 
Inosine-Iho~};lvtte-NaCl - 4.J8 g of NaCl, 7.10 g of Na2HP04 
and 2. 68 g of inosine (Nutritional Bioclwmical Co. Lot /~.4~·9) 
were dissolved in 9.50 ml water. Tne pH Has adjusted to 7.4 
with HCl and the volume was brought to 1 liter. 
Krebs Ringer-Bica:rbon2vte - 100 ml of 0. 9% NaCl, 4 ml of 
1 .1.5% KCl, J ml of 1 . 22~~ CaCl2 , 1 ml of 2 .11% KH2POLI-, 
1 ml of J. 82% }1gS04 · 7 H2 0, and 21 ml of 1. 20% NeJICOJ 
were mixed. A mixture of 5% co2/balance air was bubbled 
through the solution for 1 hour. The solution was stored 
under refrigeration in a ground glass stoppered bottle. 
Pyruvate - 8J.O mg of pyruvate (Sigma Chemical Co. 
#P-22_56, Lot J1C-1640) Here dissolved in 2 ml of water. 
100 microliters of this reae;ent made 5 ml of 10 mH suspension. 
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Triiodothyronine - 6, 0 mg of T
3 
(Nutritional Bio·~hemical 
Co. Control #8771) Here dissolved in 1 ml of wat~r Hith the 
addition of 1 cirop of dHute NaOH. Volume Has b:~ought to 
50 ml with ~.,rater. Ten microliters of a 1 to 10 dilution 
of this solution mccle 50 ml of 3.8 x 10-8 M. 
Red cells were washed with several volmnes of inosine-
phosphate-NaCl solution ard were then suspended in that solution 
to a hematocrit of H. They Here allowed to incubate for three 
hours at 37° C with shaking before centrifuging and Hashing the 
cells three times with 10 ml portions of Kl'ebs Ringer-bicarbonate. 
A suspension in Krebs Ringer-bicarbonate was made to a hematocrit 
of 28. Hemolysis Has accCJ::,plished by freezing and thaHing in a dry 
ice-acetone bath three times. The hemolysate Has centrif1.~ed for 
30 minutes at 16,000 RP.fil. 100 microliters of pyruvate Here added 
to 5 ml aliquots of hemolysEd:-e and incubated at 37° C under 5% C02/ 
balance air for 30 minutes. 10 microliters of T3 Here added to the 
appropriate flasks, and samples Here taken at intervals for DFG analysis. 
Reagents for DFG regeneration in hemolysate. 
Inosine-Pnosphate-N2,C1 - 4.38 g of NaCl, 7.10 g of Na2HP04 
and 2.68 g of inosine (Nutritional Biochemical Co. Lot 4449) 
were dissolved in 950 m1 Hater. The pH Has adjusted to 7.4 
Hi th HCl and the vol1.une was brou.ght to 1 liter. 
i. 
KJ2ebs Ringer-I3icarbona-le - 100 ml of 0.9% NaCl, 4 ml of 
1. 15% KCl, J ml of 1 . 22% CaCl2 , 1 ml of 2. L 1% Kii2Po4 , 
1 ml of J.821'; lVJgS04 ·7 H20, and 21 ml of 1.:~0% NaHco3 
were mixed. A mixture of 5% co2/balance a·l.r vras bubbled 
through the solution for 1 hour. The so1ution vras stored 
under refrigeration in a ground glass stoppered 1)ottle. 
Pyruvate - 55 mg of pyruvate (Sigma Chemical Co. #P·-2256, 
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Lot J1C-16l+O) were dissolved in 1 ml of Hater. 100 micro-
liters were used to bring 5 mls to 10 mM. 
Trii.odothyronin~- 6.0 rng of TJ (Nutritional Biochernica1 Co. 
Control #8771) Here dissolved in 1 ml of water with the 
addition of 1 drop of dilute NaOH. 'Ihe volUJne HaG brought 
to _)0 m1 with w-ater. 10 microliters of a 1 to 10 di1ution 
-8 
of this solution were used to make 5.0 m1 of J.8 x 10 M. 
Red cells Hhich had been HEtshod and resuspended in cold 
Krebs Ringer-bicarbonate to a hematocrit of 39 were closed in 
flasks under 5% C02/balance air. The celJ.s Here then hemolyzed 
by freezing and thavdng three times, using a dry ice-acetone bath 
for quick freezing. The hemolysate was centrifuged for JO minutes 
at JO,OOO x G and the supernate vias removed from the packed stroma. 
An equal volume of 10% DEAE-cellulose suspension Has added to the 
hemolysate and stirred in the cold for 20 minutes. The suspension 
was filtered and the DEAE-cellulose Has washed Hith cold 0.003 M 
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phosphate bu:'fer, pH 7. 26 until the wash t·as colorless. The 
D&\E-cell ulo~~e was extracted vlith 50 ml of 0. 5 M KCl hrice, and 
the extracts vrere pooled. 'I11e pooled ext:r3..ct Has then dialyzed 
against 0.15 M KCl containing mercaptoethanol overnight in the 
cold. 2. 5 mg of ·bovine serum al btunin, J:i':raction V, Nero added for 
each ml of enzyme extract, and the solution rras stored under 
refrigeration. 
Reagents for preparation of enzyme extract. 
1.15% KCl, J ml of 1. 22% CaCl2 , 1 ml of 2.11% IGJ:2POh, 
1 ml of J. 82% Ne;S04 · 7 H2 0 and 21 ml of 1. 20% NaHCOJ 
vrere mixed. A mixtllre of 5% co2/balance air vras bubbled 
through the solution for 1 hmrr. 'l'be solution Has stored 
under refrigeration in a ground glass stoppered bottle. 
DEAE-Cellulose_ - 100 g of Diethylaminoethyl Cellulose 
(Sigma Chemical Co., Capacity 0.86 meq/g, Medium mesh, 
Lot JOC-2340) Here added to 1500 m1 of 0.5 N HCl. The 
suspension Has alloHed to se]_arat.e and the supernate was 
decanted. The residue Has Hashed vdth Hater until the pH 
of the Hash solution Has greater than 4. Tnen 1500 ml of 
0.5 N NaOH tlere added, the suspension Has alloHed to se1)arate 
and the supernate was decanted. The residue Has Hashed vrith 
vrater until the pH rras less than 8. The residue Has then 
rrashed Hith 0.003 11 phosphate buffer, pH 7.26 until the pH 
of the vrash solution \·las the same as the buffer. A sus pen-
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sian of DEAE-cellulose in buffer Has left to stand 
refrigerated overnight, c;,fter Hhich Hashing vras continued 
until the pH Has constant. P 10% suspension of DEAE-
cellulose in lmffer Nas made. 
Hercaptoethanol - 78 mg of mercaptoethanol (:Eastman 
. Organics #4l96) Here added to lO ml l-Bter. 100 micro-
liters of this solution diluted to lOO ml made a 10-4 H 
solution. 
Q.!j_)1 KCl - 37 .J g of KCl vrere dissolved and brought to 
1 liter. 
0.15 1'1 KCl - H1. 83 g of KCl Here clissol ved and brought to 
1 liter, 100 rnl of this f>olution and 1 ml of mercapto-
ethanol Here diluted to 1 liter, and the pH was adjusted to 
7.26 with 0.01 N NaOH. 
Buffer, 0. 003 Jl1 Jhosphat~ - 0. 003 I1 Na2HP04 (426 mg/li ter) 
and 0. 003 11 NaH2I-'04 (414 mg/liter) were mixed in amounts 
sufficient to yield a pH of 7.26. 
Assay of Dl~ mutase. 
0.5 ml of a composite reagent Here placed in a cuvette and 
the rate of change of absorbance at 340 run was measured. The rate 
after the addition of glyceraldehyde-3·-phosphate dehydrogenase was 
taken as the blank reaction rate. The rate was again measured after 
the addition of the enzyme extract, and the net change in absorbance 
was taken to be proportional to the enz~rre concentration. 
..• 
Rcac;ents for D:FG mutase assay. 
Buffer- 0.5 lVI K2HP04 (8.71 g/100 ml) and 0.5 :M KH2Po4 
(6.81 g/100 ml) were miYed to a pH of 7.8~ 100 micro-
liters contained 50 micr:Jmoles of buffer. 
:Mercaptoethanol - 39.:1. mg of mercaptoethanol Here added 
to :LO ml Hater. 100 mic.roliters contained 5 micromoles of 
mercaptoethanol. 
Nicotinamide Adenine Dinucleotide (NAD) - 33.9 mg of NAD 
(Sigma Chemical Co.) #D-5755, Lot 41C-7410) Here dissolved 
in 10 ml of Hater. 100 microliters contained 0.5 micro-
moles of NAD. 
DL-G::!:Y_ceraldehyde-J-Phosphoric Acid - 4. :L me of DL-
glyceraldehyde-3-phosphoric acid (Sigma Chemical Co. 
#G-5251, Lot 011C-5220) were dissolved in 10 ml w·ater. 
100 microliters contained 0.12 rnicromoles of D form. 
D(-)3-Phosphoglyceric Acid- 18.9 mg of phosphoglyceric 
acid (Sigma Chemical Co. #P-0259, Lot 51C-5040) were dis-
solved in 10 ml of Hater. 100 microliters contained one 
micromole. 
GlyceraldGhyde-J-PhosiJllate Dehydrogenase - 20 microliters 
of enzyme suspension (Glyceraldehyde-J-phosphate dehydro-
genase, Sigma Chemical Co. #G-8379, Lot 80C-7382) were added 
to 1 ml water. 100 microliters contained J.6 units. 
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Composite Tic!:e;ent - One ml each of buffer, glyct'raldehyde-
J-phosphate, mercaptos-Ghanol, )-phosphoglyceric acid and 
NAD Here mixed in that order. 0. 5 ml 11as used per test. 
..• 
RE::ULTS AND DISCUSSION 
In an effort to mm_·e clearly define some of the changes 
taking place :i.n red cells under physiologic stress, the effects 
of ad:renal hormones on ths level of DFG have been investigated. 
Corticosterone, cortisol, testosterone and epinephrine Here 
each incub3-ted at concentrations from 1 to 1000 times their norm3-l 
free plasma levels Hith rsd cells. The resu1ts, as indicated in 
figures 7 through 10, shoH tha.t none of these hormones had a 
demonstrable effect on DfG levels. 
Allen and Rasmussen (1971) reported that epinephrine, as Hell 
as prostaglandin JD
2 
and isoproterenol had effects on the deforma-
bilit~y of the red cell membTane. Oslci et aJ. (1972) TepoTted that 
J.J x 10-5 N p:ropranolol, a blocking agent for the beta-adrenergic 
receptors, brought about a redistribu·Uon of intracellular DFG by 
causing the approximately JO% of the total Hhich they found bo1.md 
to the membrane to l)e released. This action of propranolol they 
found to be blocked by epinephrine. 
These reports evoked further interest in the role of the 
adrenal hormone epinephrine, as Hell as the other involved vasoactive 
compo1mds, in the metabolism of DPG and red cell function. 
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Figure 7. DFG levels in red cells incubat,ed Hi th corticosterone 
at 1 to 1000 times the normal free plasma level. Normal is 
100 ng/100 ml. Incubation Has carried ou·t in fortified Krebs 
Ringer-Bicarbonate under 5% co2/oalance air. 
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Ii'igure 9. D:PG- levels in red cells incubated with -tef3tosterone at 
1 to 1000 -times the normal free plar~ma level, Normal is 
30 to 1200 ng/100 ml plasma. 
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Attempts were made to reproduce the Hork of 03k: et al 
shmdng binding of DR; to reel cell membranes. Tney mac_e a 1:1 
(celJ:water) hemolysatc, ,;entrifUt_c;ed for 10 minutes at J500 RHi, 
passed the supernate thro'Igh a glass wool plug in a caJd.llary 
tube, and then centrifuged the cffluate for 15 minutes at 3500 
RPJ'-1. They a11parently perfoTmed no independent assay fcT stToma. 
ExpeTiments Here cl•me to deteTmine t.be extent of separation 
of ghosts upon the recorr!l'tended loH speed (3500 RH1) cer.trifugation 
as a function of cell:Hater ratio. The DR; concentration associ-
ated Hith the vaTious fractions Has a1so measured. SepaTation 
Has estimatecl visually, ghosts render the solution turbid, and 
by observation under phase microscopy. 
At a cell :vrater ratio of 1:10, there h'as a clear and complete 
separation of cell membTanes. Of the total :t2 ml volume, the top 
several alig_uots (of approximately 2 ml each) 1~ere truly stroma 
free. lfuen the cells and water -.;ere pTesent :i.n the ratio of 1 :1, 
however, the separation Has much less complete and in fact did not 
consistently folloH the expected pattern of increasingly more 
stroma from the top of the tube to the bottom (see Tracing I, 
figure 11). In this case, alig_uots from the middle had fewer 
stroma than the top or bottom of the tube. A possible expla-
nation for such a finding is that hemolysis HaG incomplete in 
1. I 
a 1:1 mixture, resulting in a mixture of cells in various stages 
of hemolysis and therefore with varying densities. The density 
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Figure 11. DR; distribution in 1:1 and 1:10 (cell:water) hemolysates 
centrifuged at 3500 HPH (1500 x G) for 10 minutes. 
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of the extracellular solution was extremely high clue to the very 
high her,toglobin concentration. Some :Jf the 1ess dense pa,rticles 
may Hell float rather than sediment i'l such a medium Nhen centrifujed. 
The DI-G levels for the 1 : 10 mixtures 1-rere essentially con-
stant from cell-free supernate through residue, offering no evi-
dence for binding. For 1:1 mixtures, the DFG levels were less 
predictable. In no case Nas there an apparent correlation between 
stroma content and Dl~ concentration. 1nis data is contrary to 
that reported by Oski et al (1972) Nho found approxL11ately 30% 
of total cell DFG bound to membranes in a 1:1 hemolysate. 
High speed centrifugation (3 hours at 4-8,000 x G) Has ap-
plied to a 1:1 hemolysate to achieve a better separation. Even 
though the solution Has resolved into a translucent upper and 
opa,que loNer half, phase microscopy showed the translucent super-
nate still contained a "light" to "medium" stroma count. The resi-
due (loHer half of tube) was very rich in stroma. The DFG concen-
tration of the top, miclclle and bottom sections of the tube were 
measured. 
From the data in figure 12, a layering of partially hemo-
lyzed cells may be seen, Hith those least hemolyzed being the 
most dense and containing the most DR;. This would account for 
the small difference between the DFG concentrations of the top 
versus the bottom layer. 
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Figure 12. DR:; d:is-tr:ibutlon in a 1:1 (cell:vrater) hemolysate 
centrifuged for 3 hours at 20 1 000 RHI (L~8 1 000 x G). 
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In order to determ.'.ne Hhether propranolol affected the 
ostensib1e membrane "hi.ndil!g of DIG, the data in figure 13 were 
accumulated in the presenC'e anrl absence of 3.3 x 10-5 1'1 proprano-
lol. 'lhese data give no indication of sub:c;tantial bi.nding of 
DIG to membranes. Since there is no binding shown, the question 
of an effect by proprano1ol is moot. A further experiment was 
done which included epinephrine (see figu:re 1/.j·). If th~se data 
Here to have folloHed those of Oski, the top fractions vf those 
samples containi11g propranolol + epinephrine Hould have been 
identical to the controls, while the top fractions of those sam·-
ples containing propTanolol alone v:ould have contained more DIG. 
This Has not the case, as may have been expected fol1oHing the lack 
of repeatability of the basic bind-ing phenomenon O;:;ki reported. 
The data reported so far vras in terms of DIC concentration. 
Oski et al reported their data as Dl""G/hemogJ.obin ratio. It may 
well be the case that DIG and hemogJ.obin are not re1eased pro-
portionately upon hemo1ysis, so that the results would differ 
if presented as the ratio. The propranolo1-epinephrine experi-
ment Has done vli th the data presented as DIG/hemoglobin. The 
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data, s·1own in figure 15, does not s!>ow that propranolol inhibited 
binding and epinephrine neutralized r:ropranolol. 
:3ecause of the skepticism a·bol:t the procedure used by O:::!:i 
et al to separate the stroma, the effluate from glass 1-mol fil tra-
tion Ha'=> analyz,ed on a Coul te:c Counter, Jvlodel S, to get a g_uanti-
tative red blood cell count. 
Red cells suspended in isotoni::: b1lffer to hematocrit 39 
Here passed throv.gh a 1 em siliconized glass Hool plug in a 5 ml 
plastic pipet. 
Filtered Suspension 1¥1 
Filtered Su;:;pension #2 
Unfil te:ced Sus:pension 
Hematocrit 
39 
39 
39 
4.28 
4.32 
4.36 
This shov;s that no cells Here removed by this proccd.ure. 
The Coulter Counter vms used to get information on hypo-
tonic hemolysis of red cells under conditions ranging from 1:1 
(cell:isotonic buffer) to 1:10 (cellnmter). The data in figure 16 
Has obtained, rrith the control in each case being a corresponding 
cell dilution in isotonic buffer. 
These data shorr that in fact there is incomplete hemolysis 
in 1:1 (cell:rrater), Hhich is the ratio used by Oski et al. Note 
that the mean cell. volume (HCV) of the test (hypotonic) solution 
has not reached a minimum at 1:1 (cellmater) (see figm·e 17). 
Also, from the point of vierr of the RBC count, at 1:1 (cell:vrater), 
97% of the cells Here still counted, Hhile at 1:10 (cell:water), 
only 30% were of sufficient size to be counted. At the same time, 
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Figure 16. Data from Coulter Counter on extent of hemolysis as a f~~ction of tonicity. 
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the percent hEmoglobin in the supernate increased markedly from 
1:1 (cell:~- i~ otonic) to 1:1 (cell :Hater). Hmrever, it increased 
still further at 1:5 and 1:10 (cell:Hater). 'Ihis is consistent 
with the analysis that the cells had releas8d a considerable 
portion of their hemoglobin in 1:1 (cellmater) hemolysate, but 
by no means Has hemolysis complete. 
A related effect of propranolol has also been reported 
Hhich described the protection of red cells from hypotonic hemo-
lysis by higher levels of propranolol than those used by Oski 
( Olaisen and ¢ye, 1973). Data shmdng that effect is in figure 18. 
Higher hematocrits 1...-ill be required in order to get measura1Jle 
quanti ties of DFG in the supernate. 'I'he folloHing data shoHs the 
relationship of the relative heP1.olysis to the hematocrit of the 
suspension: 
Cells Isotonic Sol_ut~sm Hematc~~rit -Relative Hemolysis 
0.3 ml 4.7 ml 5.8 36.4 
1.0 ml 4.0 ml 18.6 32.0 
1.7 ml 3.0 ml 29.2 25.6 
At hematocrits of the order of 30, it should be possible to measure 
Df~ in the supernate. 
'Ihis Has seen as a means for obtaining additional data 
relevant to the reported binding of DFG in red cells and the pro-
pranolol effect thereon. An experiment Has done in which hemoglo-
bin absorbance and DFG concentration Here measured in the supernate 
following hemolysis in water, hypotonic buffer and j_0-3 1'1 propranolol in 
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Figure 18. The protective effect of propranolol against hypotonic 
hemolysis. Hematocrit = 6. 
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hypotonic buffer. The data shown in figure 19 was obtained from 
this experimen-~. The loHer levels of DIG anl hemoglol)in in the 
supernates in T.he presence of propranolol sh m that it does in 
fact protect rPcl cells from hemolysis. The C!Onstant DJ=C/hemoglobin 
ratio indicate;; that the release of hemoglobin and D:EC are affected 
equally by the presence of propranolol. This argues against any 
effect of propranolol on p' . .rta ti ve binding. 
Since propranolol and epinephrine are structurally similar 
(see figure 20) and since O.ski et al have reported an antagonistic 
relationship betvreen them in his binding experiments, the question 
arose as to Hhether epinephrine would antagonize the protective 
effect of propranolol reported by Olaisen. The experiment shmm 
in figure 21 Hc'..S performed Hi th cells being added to the solutions 
indicated. This shoHs that epinephrine equimolar Hith propranolol 
did in fact block the protective effect of propranolol. 
Figures 22 and 23 shm: the effect of changing the concen-
tration of epinephrine while holding the propranolol level constant. 
-3 -3 There is proportionality over the range 0.2 x 10 M to 10 M. 
-4 Concentrations less than 10 H have no effect. 
The determination of the effect of changing propranolol 
concentrations in the presence of a constant amoQnt of epinephrine 
will provide information on whether the antagonistic effect of 
epinephrine can be overridden by propranolol (see figure 24). 
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Figure 19. DPG/Hemoglobin ratio in hypotonic hemolysis with and 
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epinephrine. 
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propranolol. 
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Clearly, the effect of a constant level oi epinephrine can be 
overcome. 'TI is is comparable to the effect seen v<hen the effects 
of a competii i ve enzyme inhibitor are over ;orne by an excess of the 
substrate. Such an observation is consisLmt Hith competition be-
tween the hw compounds for a common site. 
In terms of propranolol/epinephrine ratio in both cases 
(constant propranolo1 wHh changing epinephrine and constant epi--
nephrine Hith changing propranolo1), the data in figure 25 was 
obtained. The similarity of the curves Hith respect to the point 
at which protection is maximized is marked. 
The data presented so far have been for the mixing of ce1ls 
in isotonic solution with hypotonic solution containing additives. 
The cells vrere exposed sinm1taneousJy to hemolyzing conditions, 
propranolol and/or epinephrine. It was l'londered whether prior 
exposure of the cells to prorrcanolol or epinephrine v:ould have 
an effect. Dc:tta is shown in figure 26. The controls indicate 
that the basic system v:as 1wrking, i.e. there >-Tas partial hemo-
lysis in hypotonic solution Hhich v<as ameliorated by propranolol. 
If the cells >fere exposed to epinephrine before they came into 
contact vrith the propranolol in hypotonic solution, the protective 
effect of propranolol was neutralized, and hemolysis proceeded to 
the extent of approximately 90/[o. A negligible fraction of this 
was accounted for by the direct action of epinephrine on the cells 
in the isotonic solution. 
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If propranolol Has addeC to the cells in isotonic so1·.1tion 
before hypotonic hemolysis, sorn2 less hemolysis took place (Epproxi-
:mE.tely 70%) than occurred Hi th epinephrine preincubation. Ir pro-
pranolol preincubations, epino:r:hrine in the hypotonic solution had 
no effect. 
If cells Here added to hypotonic solution containing epi-
nEphrine and propranolo1 1 the protective effect of propranolol 
was still seen; no protection Wlfo observed when epinephrine and 
propranolol Here added to the cells before hypotonic exposure. 
This data raised the following questions: 
1. \'Thy the difference in effect based on the sequence of 
exposure to p::copranolol + epinephrine? 
2. vlby didn 1 t epinep!-1rLJc nevt.::eali7,e pro:pra.noluJ >·<hen 
cells Here added to hypotonic solution contc-dning both? 
J. Has the strange behavior of epinephrine related to 
the fact that. it Has dissolved in excess HCl? 'I'hat is 
to say, is the epinephrine's activity a. function of pH? 
A fresh lot of the epinephrine Has made by dissolving epi-
nephrine in an eg_uimolar amo-:.m.t of HCl. 'Ihc; follovring data Has 
obtained (see figure 27). 
i·lhen cells Hhich had been pre-incuba-ted Hi th epinephrine 
were added to hypotonic solution containing propranolol, about 
half of those cells which were subject to hemolysis ( whc.m cells + 
epinephrine Here mixc;d Hith hypotonic solution vTithout propranolol) 
Here protected_ by the propranolol. 
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Upon preincubation of cells Hith propranolol, mo::·e hemo-
lysir:-. took p1ace Hhen epin,Jpb.rinc 1·<as in the hypotonic f;olution 
than in its absence. Over:Lll, the extent of hemolysis .ms greater 
than was the case Hith preincubation with epinephrine. 
The major finding in these preincubation experiments was 
that hypotonic stress on cells 1rhicb had been preincubated. with 
a mixture of propranolo1 and epinephrine resulted in considerable 
hemo1ysis, Hhile addition of the cells to a hypotonic msdiu.'!l con-
taining propranolol and epinephrine produced very little hemolysis. 
In previous experiments (see figures 21 thru 2l~) epinephrine neu-
tralized the protective effect of pro:pranolol Hhen cells were 
added to an eq uimolar mixture of the hro. In this experiment, 
this does not appear to be the case. Epinephrine appears lnef-
fectual at neutralizing the protect:Lve effect of propranolol. 
It seems clear now that the fine l;oj_nts of the procedure 
for making up epinephrine reagent are important with regard to 
the effect of epinephrine and propranolol in hypotonic medium. 
The protocols for epinephrine T.lakeup Nhich have yielded incon-
sistent data (the two epinephrine solutions for preincubation ex-
periments) Here compared in a sing1e exper1ment. It is apparent 
in figure 28 that the manner in which the reagents Here hand1ed 
is important. By the time the ce1ls Here introduced, the recip-
ient solutions were ostensibly identical. However, the epinephrine 
made up from the more concentrated stock solution was less effective 
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in neutralizing the effect of propranolol than was thai made up 
in less concentrated forn. It is unclear f~hether this Has an 
effect of the more concer .. tra.ted epinephrine or the more concen-
trated acid (HCl) in whic1 epinephrine 1-1as dissolved. 
Experiments were performed to determine the effectiveness 
of epinephrine as a propr<:uwlol antagonist as a fm1ction of the 
concentration of the epinsphrine stock, In each ca.se, the stock 
solution was diluted to 10-3 IvJ in the hemolyzing mixture before 
the cells were added. The data in figure 29 "\'laS obtained . Extend-
ing this inquiry to loHer concentro,tions of stock solutions, it 
was seen that the effectiveness increased as concentration de-
creased until there Has essentially complete hemolysis (see firuge 30). 
These experiments show that the efficacy of epinephrine is a function 
of the concentration of the stock soluti.on. 
It may be seen i:n figw:e 30 that the pH of the buffered 
hypotonic solution dropped sharply Hith the addition of epinephrine 
solutions D through G. In order to minimize the acidification of 
the buffered hemolyzing mixture, an experiment Has done to determine 
the minimum amount of HCl reg_uired for epinephrine solubility and 
stability. The epinephrine makeup and results of the test are shovm 
in figure 31. 
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Using epinephrine reagen-t. made according to protocol C, 
figure 31, the concentration de:fendence curve in figure 3~ wa~; 
ob-;ained. This figure shows th:o.t epinephrine at concentratior s 
as low as 0.5 x 10-3 J1 r;as able to completely eliminate the pro-
tee tive effect of p:rorJranolol. This was an epinephrine/propranolol 
ratio of 0. 5, i.e. propranolol Hill be neutralized by half as much 
ep:: nephrine when the epinephrine is made up in the minimal am01mt 
of HCl, e.g. the least amount to give solubility and stability, in 
order to minimize pH problems, and at low- stock concentrations to 
maximize activity. 
It v1as found to be consistently true in the p:reincuh"Ltion 
experiment;:; that cells added to hypotonic solution after p:reincu-
bation with propranolol Here not protected to the same extent as 
cells added to hypotonic solution containing propranolol. Even 
though the final propranolol concentration was the same in both 
cases, it Has realized that the propranolol concentration in the 
preincubation Has greater than in the case when propranolol was 
in the hypotonic medium. The :results of an experiment to deter-
mine the effect of pre-incub<1ting various concentrations of pro-
p:ranolol with the cells in isotonic solution before subjecting 
them to hypotonic hemolysis is shmm in figure 33. This data shows 
that there is no effect at 10-5 J1 propranolol and maximum effect 
at 2 x 10-3 J1 propranolol in the preincubation. The maximal effect 
Hith preincubation was about half of that seen with propranolol in 
hypotonic medium. 
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'Ihe propranolol concentratj_on was 
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In order to understand the nature of the :irteraction between 
propranolol, eplnephj:ine <mel the red cell membranes, it was vwndered 
hoH strongly they wel·e bou..'1d to the membrane. In =J.,n attempt to clarify 
this point, cells 11ere in cuba ted in isotonic modi u n vii th propranolol, 
and subsequently washed with isotonic solution. 'Ihe extent of hemo-
lysis in hypotonic solution Has then measured (see figur·e 34). 
Tne first. wash removed most of the effect. of propranolol. 
'Ihis indicates that if propranolol in preincubation was bound to 
the membrane, it wasn't held very tenaciously. 'Ihis also shov-rs 
that. no permanent cbange took place in the membrane, i.e. any 
I 
effect. of propranolol on hemolysis Has directly related to its 
presence at the time of hmwlysis. 
In order to invest.ie;ate the binding of epinephrine to red 
cell membranes, tri tiurn le:tbelecl epinephrine 11as incubated Hi th 
suspensions of different hematocrjts. 'The cells Here then centri-
fuged and the radioactivity in the supernates Has measured. Figure 
35 shows that, in the absence of propranolol, the amount of epine-
phrine removed is dependent. on the hematocrit. There is le~;s epi-
nephrine in the supernate in the presence of propranolol than in 
its absence. 'Ihere are several possible explanations: 
1. Propranolol enhances binding of epinephrine to red cells. 
2. P..copranolol itself removes some amount of epinephrine. 
3. Propranolol allows entry of epinephrine into red cells, 
from Hhich it is otherwise excluded. 
~ I 
I 
1
', 
II 
I'' 
I 
-f 
I 
I 
I j 
l 
100 
90 
() () () 
·rl •rl •rl 
80 ~ ~ ~ 0 0 0 
+) 
-J.l ..J-) 
0 0 0 
Pi Pi p, 
70 >, >, ~>;J 
..c; .. c.~ .-e.-: 
Ul 
·rl 0 0 0 
Ul 
;>, 60 +' -1.) +' 
rl 
~ ~:: ~ 
.,j 
·<-I ·rl 
0 
~ rl rl rl 
OJ 0 0 0 
~50 I ri r·-1 r-1 0 0 0 0 
..J-) 
~ 
~ ~ ~ ,~ 
OJ () 
rJ cd m m 
() 40. H H ~-I ~1 •rl () (-2, p, 
r 
p, 
~I - ~ ·r-1 0 () 0 0 0 
G) 0 ~ Jj ·rl H H H fl.! H ..J-) 0 >:.' p., 
' ;:~ p, JO G) 0 -P 0 ..J-) Pi 0 ~..J-) "'-~ ""~ w m ;>, Ui 0 ,._, ~---<
:;;: ..c; .,--j ~ p., \] ..c; 
Q) 
..c; 
;>, i (/1 U) I (/1 
0 0 0 o..c: 0 m 0 n.l 0 Cl] 20 ..J-) ..J-) -1_) ..-I ,---1 ~ ,_j :;;: -rl ~s: ~ ~ ~ 0 
·rl ·rl •oi +-J.:> + "--1 + N + 01 ~ 
10 Ui Ul U) OJ ·rl OJ H U) H Ul H rl rl rl rl rl Q) r-1 OJ r-1 Q) 
rl rl rl r-1 rl rl..P ,-j +' r-i ..J-) 
OJ Q) Q) Q) 0 OJCJ-J G)Cj-j OJ CH 
0 0 0 Or·--! 0 m 0 m 0 m 
0 --1 ----
'-------
_/ 
Controls 
Figure JlL Hemolysis in cells Hhich have been pre incubated Hi th 
propranolol and 1-rashed 1d th isotonic buffer. 
t 
I 
' ~ 0 i 
.• 
97 
4-400 
4000 ~ . . ~~--® c 
3600 
3200 
2800 -
2i~OO 
2000 
1600 
1200 
800 
400 
5 0 
0 
X ~)11 0~ x~7t"',-* 
@. ~--2__ No Propranolol = G 
X. ---~~ ------
. ~ 0 
. /~ Calculated Curve ~ o 
Propra:1olol ~.cesent =X 
0 
~-;;-z__ Dilution Curve for gpinephrine 
400 300 200 100 A Epinephrine Solution 
I, l lOOO __ t 600 I 
I 
zoo 
'A Cell Suspension 
Figure 35. Labeled epinephrine in supernate after centrifuc;ation 
of isotonic red cell :=mspensio::j P.copranolol concentration 
epinephrine concentration °"' 10 H. 
,, I 
j 
I 
l 
I 
l 
f 
··' 
98 
The third explanation see.ns most plausible, given the 
ob;:;crvation that there are more :::ounts at extrapolated zero cE:Jls 
than the true zero (see dilution curve, figure 35). Tnis ind5.cates 
that in the presence of cells Hi.:.hout propranolol, the epineprrine 
is distributed j_n a smaller volur1e. Also note that a calcula-ted 
curve, b:-:Lsed on the asswnption that the epinephrine distributes 
in a volume expanded to include -'Jhe cell volwne closely resembles 
the curve in the presence of pro_?ranolol. 
There have been reports that the tby-.coid hormones TJ and 
T4 enJ1anced DFG synthesis by directly stimulating the enzyme phos-
phoglycerate mutase (Snyder aml Reddy, 1970; Gahlonbeck and Bartels, 
1968; IvJiller, Delivoria-Papadopoulos, Hiller and Oski, 1970; Snyder 
and Reddy, 1970a). There Hould be a functional advantage to E.uch 
an adaptation, since this wou:!.d aJ.loVI for increased delivery of 
oxygen to the tissues Ni thout an increase in cardiac output. Tl:1e 
resu1 ts of an experiment designed to ~3how that effect are shown 
in figure 36. Under the conditions descrlbecl by Snyder and Reddy 
as optimal, no effect on DFG level vras demonstrated, although cell 
viability is a-ttested. to by -the disappearance of glucose. 
Miller et al (I1 iller, Sw::;arman, JIJiller, Delivoria--fupadopoulos, 
Diaco, Gottlieb and Oski, 1970) reported no change in DFG levels in 
response to thyroid hormones tihen red cells Here suspended in buffer, 
but did get a net average increase in DFG of approximately JO% over 
control vlhen Hhole blood Has incuba-ted vrith TJ at a concentration of 
4-.4- micrograms per ml vrhole blood. (This hormone level is approximately 
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300 times greater than that used by Snyder and Rcd,ly and is well 
outside the physiole>gical range). The data. in figure 3? was ob-
tained from the incLbation of whole blood with T4 and T3. 
effect Has demonstrated. 
No 
A system has been descrH)ed w-hich quickly L'egenerates DIG 
in depleted rod cells (Du..h.m and Gerlach, 19?1). It involves incu~ 
bation in a solution of inosine (10 ml-1), phosphatP (50 mH) and 
pyruvate (15 mH). 'Ihe inosj_ne contributes triose phosphates from 
its ribose moiety via the hexose monophosphate shunt, phosphate acts 
as a substrate and thereby prolllotes kinase reactions, and pyruvate 
regenerates NAD via the IJJH reaction. When such a system was ob-
served in the presence of T3 , the data in figure 38 Has obtained, 
vlhich does not shm-1 a differonce in the rate of DIG synthesis. Such 
an experiment offers evidence th."l..t the cells are viable and that 
the enz,yme Hhich is ostensibly affected is capa.ble of' activity 
considerably beyond that normally seen. Under these conditions 
thyroid hormone exhibits no enhancement. 
TI1ere is evidence that DPG phosphatase is active in red 
cell hemolysates (Gerlach, Duhm and Deuticke, 1970). To determine 
Hhether DIG mutase Has active in homolysates, cells preincubated 
in inosine and phosphate Here Hashed and resuspended in Krebs Ringer-
bicarbonate and hemolyzed by freeze/thaHing. Upon addition of pyru-
vate, there Has a 40% increase in DIG in 15 minutes, indicating that 
DIG mutase vras active. The addition of thyroid hormone did not af-
fect the DFG increase. 
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Figure 38. DI-"G level in red cells in inosine-rJhosphate-pyruvat'8 
med.hun in presence of T3 . T3 
concentration = 3. ?5 x 10 M. 
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An enzyme extract Has pre~n:·ed from a red cell hemolysate 
according to the method of Snyder and Redd,r (1970a). This involved 
hemolysis by freezing and thaHing, adc"3orption of the enzymes onto 
DEAE-cellulose and their su-bsequent elutio;1. DIG mutase activity 
in the extract Has assayed acco:rcUng to tht; method of Rose (1968). 
'lhe measured activity Has the s2"me in the <cbsence of T and in its J 
-8 5 presence over the range 3.75 x 10 M to J.?5 x 10- H. 
L 
I 
... 
~he acl:cenal hormor;es cortico:Jterone, cortisol, testosterone 
and epiLephrine have been foQDd to have no effect on the level of 
DFG in red cells. Tnis still leaves open the possibility that 
these compormds may participate in red cell function and oxygen 
delivery via some other mechanism. 
Jn an investigation of the rep)rted binding of DFG to red 
cell membranes, it was found that the conditions utilized did not 
accomplish the complete hemolysis of red cells nor permit the sepa-
ration of red cell stroma from the supernate. 'lne JO% difference 
reported rras between the complete hemolysate and the supernate 
after separation of stroma, and I>roba.'.lly reflected incomplete 
hemolysis. The more comJllete analysis reported here goes further 
and shoHs the distribution of D:FG throughout the tube rmde::c condi-
tions more commonly used to effec·t, complete hemolysis. 
Propranolol was sho'm to protect red cells against hypotonic 
hemolysis. Epinephrine Has found to 1)e antagonistic to the protec-
tive action of propranolol, but the action of epinephrine could be 
overridden by an excess of propr::molol. 'Ihe important factor was 
formd to be the propranolol/epinephrine ratio. Preincubation of 
cells in isotonic solution with propranolol or epinephrine did not 
clearly define the interactions of these compounds vlith the membrane. 
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'Ihe concentration of the epinephr:i.Jw stock solution was 
foLilld to have consequences with :cegarcl to the efficacy of epi-· 
ne_::Jhrine in antagonizing prop:car olol. Activity Has found ~o IJe 
inverseJ.y proportional to the epinephrine stock concentration. 
When e:pinephrine w-as dissolved in just enough acid to solubil Lze 
it and maintain it in a stable form, half as much epinephrine 
neutral:i.z,ed propranolol. 
When propranolol Has inc leba ted in isotonic sol uti on Hi th 
the cells before hypotonic hemolysis, the maximal protective ef-
fect was found to be about half that found vlhen the propranolol 
Has mixed Hith the hypotonk so1ution before the cells Here added. 
That proprano1ol apparently exerted its effect at the instant of 
hemolysis rather tb.an by inte:cact:i ng vrith the membrane prior to 
hemolysis was indica,tecl by the f:i.ndir1g that a single >·rash with 
isotonic buffer essentially completely removed the protective 
effect. 
The amount of epinephrine removed from a buffer solution 
Has a function of the number of cells which had been suspended 
in the sol uti on, i.e. the h:i.gher the hema tocr:i.t, the less epi-
nephrine left in the supernate. In the presence of propranolol, 
more epinephrine was removed than in its absence. Tnis was the 
only piece of information Hhich did not directly support the 
hypothesis that propranolol and epinephrine vrere competing for 
a common site on the membrane during hemolysis. The possibility 
that propranolol facilitated the entry of epinephrine into the 
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cell volume was supported by the similarity of the calculated 
curve based on that asi.>UIDI'tion to the actual curve obtal_ned in 
the presence of both compcuncls. 
'I'hyroid hormones UY'der a variety of conditions w.::re found 
to have no effect on red cell DPG levels. This was in conflict 
Hith the reports of Snyder and Reddy (1970; 1970a) and Miller et al 
(Niller, L. D., et al, 1970) to the effect that DIG accumulated 
under the influence of thyroid hormones. Dm·:Lng the co1trse' of 
repeated attempts to reconcile the findings reported here with 
those other reports Hith Hhich they Here in conflict, other estab-
lishecl vmrkerc3 in tlds area of study reported their inability to 
reproduce the vwrk shoNing effects of' thyroid hormones on DIG 
levels (Dub.m, Deutickc and Gerlach, 1969; Gerlach and Dubm, 1971). 
It seems, then, that if thyroid ho:r'Iflones do affect DPG levels, as 
seems reasonable from the tcdeo1ogic2~l a:rgtunent, there are apparent-
ly significant cond.ibons Hhich have been fortuitously met by those 
who have demonstrated the effect and not by those who have been u.D-
able to shoH it. 
Among the additions to be made to the existing body of knoH-
ledge as a consequence of this project are 1) The development of 
an improved method for the assay of DIC, ba:::>cd on modifications 
of the automated method of' Atkinson (1972). Changes Here made which 
altered the sensitivity and improved the separation betHeen adjacent 
samples. 2) Further investigation and analysis of previously re-
ported effects relative to the metabolism and distribution of DIG 
I 
J 
r 
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in red cells have resulted in an alternative exphtnation to that 
sugc;ested by others :1s the l>a:::.ls for their ob:3c::~v<,tions. 3) It has 
been discovered th::;, t the ability of propranolol t) prot.ect red cel1s 
against hypotonic hemolysis Wo,s neutralized by ep:.nephrine. Tnis 
may deve1op into a method for getting a true measL:re of the bio-
1ogical activity of epinephrine preparations in arc in vit_rQ system. 
Such a measure may only be obtained currently by observing the ef-
feet of epinephrine preparations on living animah . 4) The antago-
nistic effect of epinephrine against prOJJ:canolol has bc;en charac-
terized. 5) The discovery of the fact that epinephrine efficacy 
is a function of the concentration of the epinephrine stock so1u-
tion may have consequences for the many m>es of this compound both 
in research and in therapy. 
1 ... ;,.; 
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ABSTHACT 
Several adrenal hormt.:nes 1-1ere investigated and found to have 
no effect on the level of 2,3-diphosphoglycerate (DFG) in red 
cells in :in vitro incubations. DI.:C Pas measured via the method 
----
of Atkinson, after substa"1tial modifications. 
No data was obtained which supported the report that a 
fraction of the DFG was bound to the red cell membranes. The 
difference between the DIG contents of hemolysates and supernates 
prepared. as reported in the literature 1wre probably a resuJt of 
the incomplete hemolysis Hhich rms shovm to prevail under the 
conditions used. 
Propranolol Nas c:.hown to protect red cells against hypotonic 
hemolysis, an effect -which t<as antagonizecl by epinephrine. 'IhG 
antagonist:ic action of epine:phrine coulcl b8 overridden Hhen the 
propranolol/epinephrine ratio Has E:ufficient. Pr:·eJncv.bation of 
cells in isotonic mediwn Hith epinephrine neutralized the effect 
of propranolol. If the cells were preincubated Hith pl'opranolol 
in isotonic solution, epinephrine :i.n the hemolyzing hypotonic 
solution was ineffectual. 
The activity of epinephrine solutions vras found to be 
inversely proportional to the concentrations of the stock solutions. 
When activity was maximized by limiting the stock concentration 
..• Abstract - 2 
and Hhen a minim·wn Hwunt of acid. was used to sol~1bilize and 
stabilize the epineJbrine, half as much epinephrirte neutralized 
propranolol. 
Fropranolol Has found to have about tHice the effect Hhen 
it was present in the hemolyzing solution rather tll<.~n in the iso-
tonic preincubation. That proprano1ol apparently exerted its 
effect at the instant of hemolysis rather than by interacting_ 
Hith the membrane prlor to h2moly:::.;is Has indicated by the findi:r.g 
that a i:>ingle Hash 1fi th isoton:l.c buffer essentially completely 
removed the protective effect. 
The aJ11om1t of epinephrine removed from a buffer solution 
Has a function of the number of cclJs Hhich had been suspended. 
in the solution. In the prec.:~ence of propranoloJ., more epinephrine 
Has removed than in its absence. The possibility that. propranolol 
facili t.ated the entry o:f epine.r;~hrlnc into the cell vohJJne Has 
entertained and fomld to be rca.;;onable. 
Thyroid hormones Ut"1der a variety of conditions '\~ere fo1.md 
to have no effect on red cell DIG. levels. 
